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The translational regulation by heat shock proteins (hsps) in rabbit reticJlocyte 
lysates has been studied. First, using the techniques of immunoprecipitation and Jestern 
I 
blot analysis, the interactions of the heme-regulated eIF-2a kinase (HRI) with the 90 kDa 
heat shock protein (hsp90), hsp70, and hsp56 or the EC! antigen in rabbit retic!ocyte 
I 
lysates have been determined, which indicates that HRI exists in reticulocyte lysat~s as a 
i 
I 
multiprotein complex with heat shock proteins. Second, the function of heat [ shock 
i 
proteins in regulating the activation and activity of HRI in normal or stressed conditions 
I 
including the addition of denatured proteins, heat shock, and the addition of oxidant~, such 
i 
as N-ethylmaleimide or heavy metal ions (Hg++), have been investigated. Third, td .better 
i 
I 
understand the biochemical function of the associations of HRI with hsps, the mechanism 
I 
for assembly of HRI-hsps complex, and perhaps also general mechanisms for the as~embly 
! 
of multiprotein complexes in vivo, a serious of experiments for reconstituting the HJV-hsps 
! 
. I 
complex have been carried out. Finally, based on the observations described alJlove, a 
general model for the translational regulation by heat shock proteins in rabbit retictjlocyte 
! 
lysates has been proposed. The research presented here greatly enriches our knowl~dge in 
translational control and the function of heat shock proteins and strongly suppohs the 
I 
prevailing concept that heat shock proteins, working as molecular chaperones, pl;ay the 
! 
fundermental roles in living cells. 
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The rabbit reticulocyte lysate was the first in vitro eukaryotic translation system 
developed. It is still the most efficient mammalian cell-free system, synthesizing protein at 
the same rate as the intact cell for periods of 60 min or more (Lamfrom and Knopf, 1964; 
Adamson et al., 1969; Jackson et al., 1983). Studies of the control on protein synthesis in 
rabbit reticulocytes and their lysates, have provided us with much of our understanding of 
translational regulation. The finding that heme is necessary for the initiation of protein 
synthesis (Bruns and London, 1965; Zucker and Schulman, 1968; Adamson et al.,I 1969; 
Hunt et al., 1972) was a stepping stone to our current knowledge of the translational 
regulation at the initiation stage. The principal mechanism involved in this regulation has 
gradually been elucidated. In heme-deficiency, protein synthesis in reticulocyte lySates is 
inhibited due to activation of the heme-regulated inhibitor (HRI), which specifically 
phosphorylates the a-subunit of the eukaryotic initiation factor 2 (elF-2a). 
Phosphorylation of eIF-2a results in the binding and sequestration of the reversing: factor 
(RF) which is required for the recycling of eIF-2. The unavailability of RF results, in the 
shut-off of polypeptide chain initiation (reviewed by Hunt,1979; Pain, 1986; London et al., 
1987; Hershey, 1991; Jackson, 1991). 
Inhibition of initiation via phosphorylation of eIF-2a in reticulocyte lysates is also 
observed upon the addition of low levels of double-stranded RNA (dsRNA) (Kos9wer et 
I 
al., 1972). The low level of dsRNA activates a dsRNA-dependent eIF-2a kinas~ (dsl) 
I 




al., 1979). The work presented here deals with HRI and heat shock prot~ins in 
! 
translational control. 
Initiation of Protein Synthesis in Eukaryotic Cells 
Briefly, there are four steps in the eukaryotic translational initiation pathway:i(l) the 
formation of free ribosomal subunits; (2) the formation of the 43S preinitiation co111plex; 
(3) the formation of the 48S preinitiation complex; and (4) the formation of t!:ie 80S 
initiation complex (Fig. 1) (London et al., 1987). 
First, 40S ribosomal subunits bind the initiation factors eIF-3 and eIF-4C to form a 
43S ribosomal complex, which is unable to associate with 60S subunit. Next, the eIF-
2·GTP·met-tRNAf ternary complex binds to the 43S ribosomal complex to form the 43S 
preinitiation complex. Then with the help of eIF-4A, eIF-4B, and eIF-4F, mRNA binds to 
the 43S preinitiation complex in an ATP-dependent reaction to form the 48S preinitiation 
complex. Finally, eIF-5 catalyzes the hydrolysis of the eIF-2 bound GTP, stimulating the 
release of eIF-3, eIF-4C, and eIF-2·GDP. The 48S preinitiation complex subsequently 
associates with the 60S subunit to form the active 80S initiation complex. 
eIF-2 Recycling and the Reversing Factor 
The recycling of eIF-2 after the last step in initiation requires the replacement of 
GDP by GTP, which is catalyzed by the reversing factor, RF (London et al., 1987). This 
factor has also been designated GEF, guanine nucleotide exchange factor (Panniers and 
I 
Henshaw, 1983; Pain and Clemens, 1983) and eIF-2B (Konieczny and Safer, 198:}). RF 
was originally purified from rabbit reticulocyte lysates by assaying its ability to stibulate 




1982; Matts et al., 1983). It consists of five asymmetric subunits with appro.jdmate 
molecular weights of 82, 65, 55, 40, and 32 kDa, and forms a 1: 1 complex wit~ eIF-2 
(Matts et al., 1983; Panniers and Henshaw, 1983; Konieczny and safer, 1983; AJesz et 
Figure 1. Summary of Eukaryotic Initiation of Translation (London et al., 1987). 
Numbers in circles refer to eukaryotic initiation factors. 






























al., 1979; Siekierka et al., 1981). RF catalyzes the recycling of eIF-2 by markedly 
stimulating the rate of dissociation of GDP from the eIF-2·GDP complex (Siekierka et al., 
1982; Matts et al., 1983; Panniers and Henshaw, 1983; Mehta et al., 1983; Pain et al., 
1983; Matts et al., 1988). The binding of RF to eIF-2 decreases the affinity of eIF-2 for 
GDP (Kd GDP=l.8x10-7 M) and increases the affinity of eIF-2 for OTP (Kd 
GTP=l.7xl0-7 M) (Konieczny and Safer, 1983; Safer, 1983). Since OTP is present 
physiologically at concentrations 10- to 20-fold greater than GDP (Jagus and Safer, 1981; 
Safer et al., 1982), the net effect is that upon the binding of RF to eIF-2•GDP, OTP is 
exchanged for GDP. Thus, in the presence of Met-tRNAf, the formation of the eIF-
2•GTP•Met-RNAf ternary complex is promoted (London et al., 1987). RF catalyzed 
recycling of eIF-2 may be summarized as: 
RF+ (eIF-2•0DP) <==> (RF•elF-2) + GDP 
(RF•elF-2) + OTP <==> RF+ (elF-2•GTP) 
(eIF-2•GTP) + Met-tRNAf <==> (eIF-2•Met-tRNA~GTP) 
Inhibition of Initiation and HRI 
The recycling of eIF-2 is disrupted by the heme-regulated eIF-2a kinase (HRI) and 
dsRNA-dependent eIF-2a kinase (dsl) (London et al., 1987). HRI is a cAMP-
independent kinase, which specifically phosphorylates the 38 kDa a-subunit of eIF-2 (elF-
2a) (Levin et al., 1976; Kramer et al., 1976; Ranu and London, 1976; Farrell et al., 1977; 
Gross and Mendelewski, 1977; Levin and London, 1978; Ernst et al., 1978). The 
phosphorylated [eIF-2(aP)•GDP] binary complex interacts with RF to form a [RF•elF-
i 
2(aP)] that is not readily dissociable and therefore non-functional (Fig. 2) (Mattsl et al., 
I 
1983; Hurst and Matts, 1987). Since RF is present in lysates at a limiting concentration 
relative to eIF-2 (Matts et al., 1983; Thomas et al., 1984), the phosphorylation of only 20-
40% of lysate eIF-2 is sufficient to sequester all the lysate RF and to shut off initiation of 
protein synthesis (Matts and London, 1984). 
' 
' 
Figure 2. Effect of Phosphorylation of eIF-2a. on Availability of Reversing Factor for 
Recycling of eIF-2 (London et al., 1987). 
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Highly purified HRI has been characterized as a dimer (-150 kDa) of a single 
polypeptide (Trachsel et al., 1978; Hunt, 1979) with a sedimentation coefficient of -6.6S 
in glycerol gradients (Levin et al., 1980). On sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE), HRI migrates as an 80-92 kDa molecule, depending upon 
the percentage of the polyacrylamide gel (London et al., 1987; Chen et al., f99la). 
Recently, the cDNA coding for HRI has been cloned and sequenced (Chen et al., 1991b). 
The HRI cDNA contained a G+C rich (80%) 5'-flanking region and a 1878 nucleotide long 
open reading frame that encodes a 626-amino acid polypeptide (Chen et al., 1991b). It 
contains all eleven catalytic domains of protein kinases and the consensus sequences of 
protein-serine/threonine kinases (Hanks et al., 1988; Chen et al., 1991a,b). 
HRI is present in hemin-supplemented reticulocyte lysates in an inactive form 
(proinhibitor) (Gross and Rabinovitz, 1972; Hunt, 1979). It is activated in lysates by heme 
deficiency (Howard et al., 1970; Maxwell et al., 1971; Gross and Rabinovitz, 1972). 
During heme-deficiency HRI is thought to go through a multistage process of activation: 
progressing from an inactive proinhibitor form to a hemin-reversible form, then to an 
intermediate, and finally to a form that is irreversibly activated (Hunt, 1979). The 
formation of the irreversible inhibitor is prevented by the presence of hemin. HRI can also 
be activated in hemin-supplemented reticulocyte lysates by treatment with the sulfhydryl 
reagent N-ethylmaleimide (NEM) (Kosower et al., 1972; Ernst et al., 1978a,b), oxidized 
glutathione (GSSG) (Kosower et al., 1972; Ernst et al., 1978a,b), high partial pressure of , 
02 (Almis-Kanigur et al., 1982), ethanol (Wu, 1981), heavy metal ions (Hurst et al., 1987; 
Matts et al., 1991), and heat shock (Bonanou-Tzedzki et al., 1978;Ernst et al., 1982). 
I 
However, little is known about the mechanism for the activation of HRI undeJ these 
! 
conditions. 
Heat Shock Response and Heat Shock Proteins 
9 
The exposure of cells from a wide variety of species to an increase in temperature 
results in the enhanced synthesis of a small number of highly conserved proteins, the heat 
shock proteins (hsps) (Ritossa, 1962; Schlesinger et al., 1982; Craig, 1985; Lindquist, 
1986). This phenomenon has been called the heat shock response even though recovery 
from anoxia, ethanol, inhibitors of oxidative phosphorylation, and a number of other 
chemicals which induce the synthesis of the same proteins. From bacteria to human being, 
this response is universal. It is found in nearly every cell- and tissue-type of multicellular 
organisms, in explanted tissues, and in cultured cells. 
The heat shock response is characterized by the transcriptional activation of a 
number of "heat shock" genes and is usually accompanied by a shutdown of normal protein 
synthesis at the level of initiation and the selective translation of the mRNAs encoding for 
heat shock proteins (Lindquist and Craig, 1988; Morimoto et al., 1992). Therefore, the 
heat shock response is regulated at both transcriptional and translational levels (Fig. 3). 
In prokaryotes, as examplified by Escherichia coli, the major heat shock proteins 
are coded by single genes expressed constitutively at all temperatures. The heat shock 
response is positively regulated at the transcriptional level by the cr32 polypeptide, the 
product of the rpoH (htpR) gene and by the cr24 polypeptide (Neidhardt and VanBogelen, 
1987; Gross et al., 1990; Georgopoulos et al., 1990). The gene coding for cr24 has not 
been identified. 
In eukaryotes, the heat shock response is controlled mostly at the transcriptional 
level by a positively acting heat shock factor (HSF), which binds to specific regions of 
DNA called the heat shock element (HSE). HSEs contain repeats of the pentameric 
sequence nGAAn, located upstream of heat shock gene promoters (Sorger, 1991; 
Hightower, 1991). Recent reports have indicated the existence of multiple heat shock 
factors, some of which are themselves heat shock inducible (Scharf et al., 1990; Schµetz et 
al., 1991; Rabindran et al., 1991; Sarge et al., 1991). In the yeast Saccharoi,nyces 
I 
cerevisiae, HSF constitutively binds DNA and undergoes heat-induced phosphorylation 
Figure 3. Heat Shock Response and Its Regulation. 
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with an increase in the transcriptional activity of the adjacent gene (Sorger, 1990). In 
higher eukaryotes, HSF is maintained in a non-DNA binding state in unstressed cells. In 
response to heat shock, HSF oligomerizes and binds to the HSEs in the promoters of all 
heat shock-responsive genes (Jakobsen and Pelham, 1988, 1991; Westwood et al., 1991; 
Abravaya et al., 1991a, 1991b; Clos et al., 1992;Jurivich et al., 1992; Rabindran et al., 
1992). 
Heat shock proteins (hsps) are generally defined as those whose synthesis is 
sharply and dramatically induced at high temperatures. They show a remarkable 
conservation throughout evolution. The proteins are named according to their apparent 
molecular weights on SOS-PAGE and placed into different families based upon structural 
homologies. Very often in eukaryotes each family of hsps includes several subsets: HSCs 
(heat .s.hock £,ognates) which are expressed constitutively; HSPs (heat .s,hock ]2.roteins) 
which are largely expressed under conditions of stress; and sometimes a third class of 
proteins which are expressed constitutively, but whose rate of synthesis is significantly 
augmented following stress (Ang et al., 1991). The synthesis of some members of this last 
category is increased following glucose starvation, and they have been named GRPs 
(glucose regulated nroteins). 
Heat shock proteins function to protect cells during heat shock or related stresses, 
but they are also important components of normal cells. Some heat shock proteins are also 
molecular chaperones (Ellis and van-der Vies, 1991; Georgopoulos, 1992). Under normal 
cellular conditions, hsps appear to carry out a diversity of essential functions mediated 
primarily by their binding to other proteins. Through protein-protein interactions, hsps are 
I 
thought to assist in such actions as intracellular protein trafficking and folding-unfol1ing of 
proteins. In some cases, these interactions directly or indirectly influence the actitity of 
other proteins (Lindquist and Craig, 1988; Welch, 1990; Schlesinger, 1990; Gethirtg and 
Sambrook, 1992; Edwards et al., 1992; Georgopoulos, 1992). 
13 
The 90 kDa heat shock protein (hsp90), the 70 kDa heat shock protein (hsp70), and 
the 56 kDa heat shock protein (hsp56) are abundant in cells. Hsp90 and hsp70 have been 
shown to associate specifically with a number of physiologically important viral and 
cellular proteins including: steroid hormone receptors; the oncogene product tyrosine kinase 
pp6ov-src; the antioncogene product p53, and HRI (Courtneidge and Bishop, 1982; Brugge 
I 
et al., 1983; Evans, 1988; Matts and Hurst, 1989; and Hainaut and Milner, 1992). 
Recently, hsp56 has been found to be a binding protein for the immunosuppressant FK506 
(Lebeau et al., 1992; Massol et al., 1992; Ruff et al., 1992; Tai et al., 1992; Yem et al., 
1992). Therefore, research into the functions and mechanism of action of heat shock 
proteins in cells has become one of the hottest areas in biochemical and biomedical 
sciences. 
CHAPTER II 
HRI/HEA T SHOCK PROTEINS COMPLEX 
Introduction 
The rabbit reticulocyte lysate has been commonly used as a model system for 
studying the regulation of protein synthesis at the level of translation because of its lack of 
interfering transcriptional effects (Ochoa, 1983; Pain, 1986; Mattews, 1986; and London et 
al., 1987). The inhibition of initiation of protein synthesis in heme-deficient rabbit 
reticulocytes and their lysates is due to the activation of a heme-regulated inhibitor (HRI) 
which specifically phosphorylates the 38-kilodalton a-subunit of the eukaryotic initiation 
factor eIF-2 (eIF-2a) (Levin et al., 1976; Kramer et al., 1976; Ranu and London, 1976; 
and Farrell et al., 1977). The phosphorylation of eIF-2a results in the inhibition of protein 
chain initiation upon sequestration of the reversing factor (RF) responsible for eIF-2 
recycling (Matts et al., 1983; Siekierka et al., 1983). Since the amount of RF present in the 
lysate is much lower than the amount of eIF-2 present, phosphorylation of only 20-40% of 
the eIF-2a present is sufficient to render RF unavailable to catalyze OTP/GDP exchange 
(Matts and London, 1984; Matts et al., 1986). 
Inhibition of protein synthesis in hemin-supplemented rabbit reticulocyte lysates 
occurs in response to a variety of conditions such as depletion of glucose-6-phosphate 




1984), addition of ethanol, sulfhydryl reactive agents, or oxidants (Wu, 1981; Kosower et 
al., 1972; Gross and Rabinovitz, 1972; Ernst et al., 1978; Palomo et al., 1985; Hurst et 
al., 1987), and heat shock (Bonanou-Tzedzki et al., 1978; Ernst et al., 1982). Many of 
these same agents or conditions usually induce the heat shock or stress respoµse in 
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eukaryotic cells (Craig, 1985; Lindquist, 1986; Lanks, 1986, Bond and Schlesinger, 
1988). The inhibition of protein synthesis under these conditions occurs at least in part due 
to the activation of HRI. Phosphorylation of eIF-2a in response to heat shock has been 
reported in He La and Ehrlich ascites cells (Duncan and Hershey, 1984; De Benedetti and 
Baglioni, 1986; Scorsone et al., 1987), apparently due to the activation of an eIF-2a kinase 
with antigenic properties similar to HRI (DeBenedetti and Baglioni, 1986). However, the 
mechanism for the activation of HRI is not well understood. Studies have indicated that the 
capacity to reduce disulfide bonds present in proteins is required for maintaining HRI in an 
inactive form in hemin-supplemented reticulocyte lysates (Jackson et al., 1983; Matts et al., 
1991). However, whether it is the redox status of sulfhydryl groups within HRI or some 
other cytosolic proteins that regulate the activity of HRI has not yet been determined. 
Prokaryotic and eukaryotic cells respond to heat shock and certain other 
environmental abuses by synthesizing a small set of highly conserved proteins, heat shock 
proteins (hsps) (Ritossa, 1962; Schlesinger et al., 1982; Craig, 1985, Lindquist, 1986; 
Lindquist and Craig, 1988; Pelham, 1989; Schlesinger, 1990; Ang et al., 1991). The 
functions of hsps have long been a matter for speculation. It is widely assumed that these 
proteins protect cells from the effects of stress and act as molecular chaperones and 
foldases, mediating the transport and folding of nascent polypeptide chains and their 
assembly into or their disassembly from oligmeric structures (Pelham, 1984; Craig and 
Jacobsen, 1985; Pelham, 1986; Welch and Suhan, 1986; Lindquist and Craig, 1988; 
Beckman et al., 1990, Ellis and van der Vies, 1991; Wickner et al., 1991; Georgopoulos, 
1992). The mechanisms of action of a number of hsps remain unclear. I 
I 
Several major heat shock proteins (hsp90, hsp70, and hsp60) are known\ to be 
members of multi-gene families (Lindquist, 1986; Schlesinger, 1990; Hightower, j 1991; 
Sorger, 1991). Some hsps are constitutively expressed in cells at normal temperatures and 
are abundant in the cytoplasm (Lindquist, 1986). The constitutively expressed heat shock 
proteins have been proposed to play a role in mediating the transport and folding of n!ascent 
I 
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polypeptides while the stress induced ones have been proposed to play a role in protein 
renaturation (Pelham, 1986, 1989; Rothman, 1989; Hartle and Newpert, 1990; Beckman et 
al., 1990; Morimoto et al., 1990; Ang et al., 1991; Sherman and Goldberg, 1992; 
Beckman et al., 1992; Georgopoulas, 1992). 
The constitutively expressed form of the hsp90 family is abundant in the cytoplasm 
of normal eukaryotic cells, and has been found to form noncovalent complexes with a 
variety of cellular proteins (Schlesinger, 1990). Most steroid hormone receptors appear to 
be associated with the constitutively expressed form of hsp90 prior to the activation of the 
receptor upon steroid binding (Dougherty et al., 1984; Joab et al., 1984; Sullivan et al., 
1985; Sanchez et al., 1985; Schuh et al., 1985; Catelli et al., 1985; Mendel et al., 1986; 
Redeuilh et al., 1987; Sanchez et al., 1987; Howard and Distelhorst, 1988; Denis et al., 
1988; Simth et al., 1990). Another protein, the ECl antigen (also termed p59) which 
reacts with the KN382/EC1 monoclonal antibody, has also been shown to be a common 
component of several untransformed rabbit steroid hormone receptors (Tai et al., 1986; 
Sanchez et al., 1990). The ECl antigen or p59 has been identified as a heat shock protein 
called hsp56 (Sanchez, 1990) and a binding protein for the immunosuppressant FK506 
(Yem et al., 1992; Tai et al., 1992). Studies have demonstrated that the constitutive form 
of hsp70 associates with the progesterone and glucocorticoid receptors (Estes et al., 1987; 
Kost et al., 1989; Sanchez et al., 1990; Smith et al., 1990). Similarly, HRI has been 
demonstrated to associate with hsp90 in hemin-supplemented reticulocyte lysates in situ 
(Matts and Hurst, 1989), and hsp90 has been reported to affect the activation or activity of 
partially purified HRI in vitro (Rose et al., 1989; Szyszka et al., 1989). To understand the 
I 
mechanism of the regulation of HRI activation or activity, we first characterized th~ HRI-
1 
hsp90 complex. The data reported here indicated that, like steroid hormone receptors, HRI 
I 
interacts with hsp90, hsp70, and hsp56 (the ECl antigen) to form a complex in hemin-
supplemented reticulocyte lysates. The association of HRI with hsp90 and the ECl antigen 
I 
is hemin dependent, while the interaction of HRI with hsp70 is not hemin dependent. The 
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data suggest that the heat shock proteins may play a role in regulation of HRI activation and 
activity. 
Materials and Methods 
Materials 
Reticulocyte lysates were prepared from anemic rabbits as described (Hunt et al., 
1972), using buffered saline containing 5 mM glucose to wash the reticulocytes prior to 
their lysis (Matts et al., 1991). Goat anti-mouse IgM and IgG were obtained from Jackson 
Immunoresearch Laboratories. Apyrase (grade VIII), nitro blue tetrazolium (NBT), 5-
bromo-4-chloro-3-indolyl phosphate (BCIP), p-nitrophenyl-agarose, mouse IgM (TEPC 
183) and mouse IgG (MOPC 21) were obtained from Sigma. Alkaline phosphatase-
conjugated to rabbit anti-mouse IgG and goat anti-rabbit IgG were obtained from ICN. L-
[14C]Leucine (340 mCi/mmol) and [y-32P]ATP (1000-3000 Ci/mmol) were obtained from 
Du Pont-New England Nuclear. eIF-2 was isolated from reticulocyte lysate as described 
(Hurst et al., 1987). Anti-hsp90 IgM monoclonal antibody (8D3) (Perdew, 1988; Perdew 
and Whitelaw, 1991) was provided by Dr. Gary H. Perdew (Purdue University), anti-
hsp90 IgG monoclonal antibody (AC88) (Riehl et al., 1985) was provided by Dr. David 
Toft (Mayo Clinic, Rochester, MN), KN382/EC1 anti-p59 IgG monoclonal antibody 
(ECl) (Tai et al., 1986) was provided by Dr. Lee E. Faber (Medical College of Ohio, 
Toledo, OH), the N27F3-4 (N27) (Kost et al., 1989) and C92F3A5 (C92) (Welch and 
Suhan, 1986) anti-hsp70 IgG monoclonal antibodies were provided by Dr. William J. 
Welch (UC San Francisco), and the rabbit anti-hsp90/hsp70 polyclonal antiserum (4322) 
(Erhart et al., 1988) was provided by Dr. Stephen J. Ullrich (NCI, NIH). The anti-HRI 
IgG monoclonal antibody (Pal et al., 1991) was provided by Dr. Jane-Jane Chen (MIT). 
Purified p59 (the ECl antigen) from rabbit uterus cytosol (Tai et al., 1986) was provided 
by Dr. Ping-Kaung Tai (Medical College of Ohio, Toledo, OH). 
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General Procedures and Buffers 
Protein synthesis was carried out at 30 °C in standard reticulocyte lysate reaction 
mixtures without the addition of [14C]leucine as described (Hunt et al., 1972; Ernst et al., 
1978). Hemin supplemented lysates contained 20 µM hemin-HCI. Samples were 
denatured in SDS sample buffer followed by separation in 10% SDS-PAGE gels 
(9x14x0.15 cm; acrylamide:bis = 37.5:1) for analysis (unless noted otherwise). Proteins 
separated by the gels were transferred to Immobilon-P (Millipore) at a current density of 
2.5 mA/cm2 for 40 min for Western blot analysis as previously described (Matts and 
Hurst, 1989). Buffers: 10 mM Tris-HCI (pH 7.5), TB; 10 mM Tris-HCI (pH 7.5) 
containing 50 mM NaCl, TB/50; 10 mM Tris-HCI (pH 7.5) containing 150 mM NaCl, 
TBS; 10 mM Tris-HCI (pH 7.5) containing 500 mM NaCl, TB/500; lxSDS sample 
buffer, 62.5 mM Tris-HCI (pH 6.8), 5% SOS, 90 mM dithiothreitol, 5% glycerol, and 
0.005% Bromophenol Blue; alkaline phosphatase reaction buffer, 100 mM Tris-HCI (pH 
9.5) containing 100 mM NaCl, 100 mM Mg(OAc)i, 300 µg/ml NTB and 150 µg/ml BCIP. 
Immunoprecipitations 
p-Nitrophenyl-agarose was rinsed free of isopropanol, and was coupled to goat 
anti-mouse IgG (GAG) or goat anti-mouse IgM (GAM) as previously described 
(Livingston, 1975; Matts and Hurst, 1989). The procedure is identical to that used for 
coupling antibody to cyanogen bromide activated-agarose. However, the bond formed 
during the coupling does not generate a positive charge, which significantly reduces the 
non-specific binding of hsp90, HRI and other lysate proteins to the matrix during the 
,, 
immunoadsorptions (Matts and Hurst, 1989). The preparations contained approxit~ately 
1.6 mg of antibody coupled per ml of packed agarose. GAG-agarose and GAM-agarose 
were used as a 1: 1 slurry in TBS. The following general procedure describes the quantities 
of antibodies that were determined to quantitatively adsorb hsp90, ECl antigen or HRI 
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from 10 µl of reticulocyte lysate protein synthesis mix: for the adsorption of hsp90, 8D3 
anti-hsp90 monoclonal antibody (rnAb) from 62.5 µl of ascites fluid was bound to 87 .5 µl 
of GAM-agarose; for the adsorption of the ECl antigen, 62.5 µl of ECl rnAb (2.8 mg/ml) 
was bound to 100 µl of GAG-agarose; or for the adsorption of HRI, anti-HRI rnAb F 
from 8 µl of ascites fluid was bound to 20 µl of GAG-agarose. Non-immune control 
' 
incubations contained equivalent volumes of TEPC 183 mouse IgM or MOPC 21 mouse 
IgG ascites, with a concentration of approximately 5 mg of antibody per ml. 
Antibodies were bound to the GAM or GAG-agarose for 2 hours on ice, with 
stirring every 15 min. The GAM- or GAG-agarose was then washed sequentially with 0.5 
ml each of: TBS; TB/500; TBS; and protein adsorption buffer (either TB or TBS, with or 
without 20 µM hernin-Cl as indicated in the legend of the figures). The GAM- or GAG-
agarose was pelleted by a 10 sec centrifugation (full speed burst) in a Brinkman model 
5415 rnicrofuge. The adsorption buffer contained 20 µM hernin-Cl for the 
irnrnunoadsorption of proteins from heroin-supplemented protein synthesis mixes. Rabbit 
reticulocyte lysates were incubated under standard conditions for protein synthesis (Hunt et 
al., 1972; Ernst et al., 1978) in the presence (heroin-supplemented lysates) or absence 
(heme-deficient lysates) of 20 µM hernin for 20 min at 30°C. After the removal of excess 
adsorption buffer from the GAM- or GAG-agarose pellets containing the bound antibodies, 
10 µl of protein synthesis mixes were added directly for the adsorption of hsp90, the ECl 
antigen, or HRI, and their associated proteins. Samples were incubated at 4°C for 90 min 
with continuous mixing. The samples were then diluted ten fold with 90 µl of adsorption 
buffer, and the nonadsorbed proteins (supernatants) were separated from the p~oteins 
I 
adsorbed to the agarose (pellets) by centrifugation. Supematants were removed and 1stored 
at -70°C for further analysis. For the analysis of hsp70 associated with hsp90, the ECl 
antigen, or HRI, we found it is necessary to dilute the protein synthesis mixes ten fold with 
adsorption buffer (90 µl) prior to the 90 min adsorption of the proteins, to reduce the 
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nonspecific binding of hsp70. This resulted in a slightly less efficient adsorption of HRI in 
association with the hsp90 or the ECl antigen. 
The pellets were then washed five times with 0.5 ml of the buffers described below 
to remove nonadsorbed proteins: For the adsorption of hsp90 or the ECl antigen, and their 
associated proteins with the 8D3 anti-hsp90 or the ECl mAbs, the pellets were washed 
sequentially: once with TB, twice with TB/50, and twice with TB. For the adsorption of 
HRI and its associated proteins with the anti-HRI mAb F, the pellets were washed 5 times 
with TBS (for the analysis of associated hsp90), or the pellets were washed sequentially: 
once with TBS; three times with TBS containing 1 % sodium deoxycholate (DOC), 1 % 
Triton X-100, and 0.1 % SOS; and once with TBS (for the analysis of associated hsp70). 
Pellets were diluted with an equal volume of TB, and stored at -70°C prior to analysis. 
Samples were prepared for SOS-PAGE by addition of one volume of 2xSOS sample buffer 
followed by heating in a boiling water bath for 2.5 min. 
Two proteins, present in ascites fluid, with molecular weights and immunological 
properties similar to heat shock protein cognate 73 and hsp72 (Welch and Suhan, 1986; 
Kost et al., 1989), were non-specifically bound to GAM- and GAG-agarose. These 
proteins were not removed from the pellet by washing with high salt (0.5 M NaCl) or upon 
incubation of the pellet with MgATP. The affinity of the anti-HRI mAb F was high enough 
that in experiments examining the association of hsp70 with HRI, non-specifically bound 
proteins were removed from the pellets by washing with TBS containing detergents as 
described above. In experiments examining the interaction of hsp70 with hsp90, proteins 
specifically adsorbed with hsp90 by the 803 anti-hsp90 mAb were eluted from the pellets 
I 
by washing with high salt. Excess buffer was removed from the pellet, and adsorbed 
proteins were eluted by washing twice with 3 volumes of TB/500 (30 µl of buffer per 10 µl 
of packed agarose), followed by wash with TB/50; the washes were combined; and 
samples were prepared for SDS-PAGE after the addition of 1/4 volume (30 µl) of 4xSOS 
sample buffer as described above. The high salt elution also facilitates the detection of 
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hsp70 specifically associated with hsp90, since most of the IgM, whose heavy chain 
migrates with a molecular weight of approximately 70 kDa, remains bound to the GAM-
agarose. 
Western Blot Analysis 
Samples were separated by SDS-PAGE, and proteins were transferred from gels to 
Immobilon-P membrane for Western blot analysis as described above. Blots were blocked 
with TBS containing 2.5 mg/ml bovine serum albumin (BSA) or TBS containing 5% (w/v) 
non-fat dry milk (skim milk, Difeo Laboratories) for one hour at room temperature. The 
primary antibody was then reacted with the blots at 4 °C overnight. After reacting with the 
primary antibodies, the blots were washed twice with TBS containing 0.5% Tween-20, 
once with TBS, and then blocked with TBS containing 10% heat inactivated fetal calf 
serum (IFCS) or 5% (w/v) skim milk prior to reaction with alkaline phosphatase-
conjugated rabbit anti-mouse IgG or goat anti-rabbit lgG diluted 1: 1000 in TBS containing 
1 % IFCS or 1 % skim milk for two hours at room temperature. Blots were washed twice 
with TBS containing 0.5% Tween-20, and twice with TBS. Proteins were then detected 
by incubating blots in alkaline phosphatase reaction buffer at 35°C for 1 to 5 min. 
For the detection of HRI, ascites fluid containing the anti-HRI mAb F was diluted 
1:250 in TBS containing 500 µg/ml BSA (TBS/BSA). AC88 mAb (20 µg/ml) in 
TBS/BSA, or 4322 anti-hsp90/hsp70 antiserum diluted 1:50 in TBS containing 1 % (w/v) 
skim milk, were used for the detection of hsp90 associated with the ECl antigen or HRI, 
respectively. ECl mAb (20 µg/ml) in TBS/BSA was used for the detection of the ECl 
' 
I 
antigen. A mixture of N27 and C92 mAbs each diluted 1 :2000 in TBS/BSA was used for 
the detection of hsp70. 
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Results 
Interaction of HRI with hsp90 is hemin dependent 
The 8D3 anti-hsp90 monoclonal antibody is one of two mAbs that are currently 
available which binds to steroid hormone receptor-hsp90 complexes in mammals (Perdew, 
I 
1988; Perdew and Whitelaw, 1991). The 8D3 mAb quantitatively removes hsp90 from 
both hemin-supplernented (Fig. 4) and heme-deficient rabbit reticulocyte lysates (data not 
shown, see Chapter IV). To verify the association of hsp90 with HRI, the 803 anti-hsp90 
mAb GAM-agarose pellets were separated by SOS-PAGE followed by Western blot 
analysis using the anti-HRI mAb F (Pal et al., 1991). The anti-HRI mAb F detected HRI 
with an estimated molecular weight from 88 to 92 kDa, which migrates slightly in front of 
hsp90 under the SDS-PAGE conditions described above (Fig. 5). HRI was clearly co-
immunoadsorbed with hsp90 by 803 anti-hsp90 mAb from hemin-supplemented 
reticulocyte lysates (Fig. 5). Significantly less HRI was present in the 8D3 anti-hsp90 
immune pellets from heme-deficient lysates. The association of HRI with hsp90 appeared 
to be stabilized by the presence of hemin in the adsorption buffer, as the amount of HRI co-
immunoprecipitated with hsp90 decreased significantly at hemin concentrations below 5 
µM (Fig. 5). We observed that in heme-deficient lysates, HRI could reassociate with 
hsp90 over a 90 min time period of the immunoadsorption, if 20 µM was added to the 
adsorption buffer. The reassociation of HRI with hsp90 due to the addition of hemin to 
heme-deficient lysates was time and temperature dependent (data not shown, see Chapter 
IV). 
Hsp90 interacts with hsp70 and the ECl antigen in rabbit reticulocyte lysates. 
The ECl antigen, also termed p59, has been identified as a heat shock protein 
hsp56 (Sanchez, 1990) and a binding protein for the immunosuppressant FK506 (Yem et 
al., 1992; Lebeau et al., 1992; Tai et al., 1992). The ECl antigen and hsp70 are common 
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components of several steroid hormone receptor-hsp90 complexes (Tai et al., 1986; Kost et 
al., 1989;Smith et al., 1990; Renoir et al., 1990; Sanchez et al., 1990a,b ). To investigate 
whether the ECl antigen and hsp70 interact with the HRI-hsp90 complex, the 803 anti-
hsp90 immune pellets were analyzed by Western blotting with the anti-ECl mAb and the 
N27/C92 anti-hsp70 mAbs, respectively. Probing with the ECl mAb, the ECl antigen 
was detected as a 56 kDa band which comigrated with immunoaffinity purified p59 from 
rabbit uterus cytosol (Fig. 6A). The 8D3 anti-hsp90 mAb co-adsrobed the ECl antigen 
from both heroin-supplemented and heme-deficient lysates (Fig. 6A). Another protein 
band with a molecular mass of approximately 52 kDa, which reacted with the ECl mAb, 
was also observed to be present in both the 803 pellets and the rabbit uterine ECl antigen 
preparation (Fig. 6A). We have not yet determined whether this 52 kDa protein is a 
proteolytic fragment of the ECl antigen, or a unique, but antigenically similar protein, 
which is also present in the complex with hsp90 and the ECl antigen. 
Using a mixture of N27 and C92 mAbs, hsp70 was detected to be specifically co-
adsorbed with hsp90 by the 803 mAb from rabbit reticulocyte lysates (Fig. 6B). The 
association of hsp90 with hsp70 is not hemin dependent, since hsp70 could be co-
immunoprecipitated by the 803 anti-hsp90 mAb from both heroin-supplemented and heme-
deficient lysates (Fig. 6B). 
The ECI Antigen interacts with HRI, hsp90, and hsp70. 
Though the data described above suggest that the ECl antigen interacts with hsp90 
in both heroin-supplemented and heme-deficient lysates, there is no direct evidence for the 
I 
interaction of ECl antigen with HRI or the HRI-hsp90 complex in rabbit reticulocyte 
lysates. To verify the interaction of the ECl antigen with HRI or the HRI-hsp90 complex, 
the proteins co-adsorbed with the ECl antigen were analyzed by Western blotting. The 
ECl mAb quantitatively removed the ECl antigen from both hemin-supplemented and 
heme-deficient reticulocyte lysates (Fig. 7). Western blot analysis using the anti-HRI mAb 
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Fas a probe indicated that approximately 80% of the HRI was co-adsorbed togeth~r with 
the ECl antigen from hemin-supplemented lysate, while little HRI was co-adsorbe~ from 
I 
heme-deficient lysates (Fig. 8). When the AC88 anti-hsp90 mAb was used for probing the 
Western blot, we observed that hsp90 was co-adsorbed with the ECl antigen froi both 
hemin-supplemented and heme-deficient lysares (Fig. 9A). The EC! mAb only coadrorbed 
a fraction of the hsp90 from the lysates, indicating that not all of the ECl antigen associates 
with hsp90 in lysate and that a pool of hsp90, which is not associated with thb ECl 
antigen, is present (data not shown). The interaction of the ECl antigen with hs~70 in 
reticulocyte lysates was verified by blotting the ECl mAb immune pellets with a miJure of 
the N27 and C92 anti-hsp70 mAbs (Fig, 9B). Like hsp90, the interaction oft+ EC! 
antigen with hsp70 was not hemin-dependent (Fig. 9B). Consistently less hsp7l0 was 
adsorbed together with the ECl antigen from hemin-supplemented than from reme-
deficient lysates. A similar observation was also observed in the frarions 
immunoadsorbed by the 8D3 anti-hsp90 mAb from hemin-supplemented and heme-
deficient lysates (Fig. 6B). 
HRI interacts with hsp90 and hsp70. 
The anti-HRI mAb F can quantitatively remove HRI from both hlemin-
supplemented and heme-deficient reticulocyte lysates (Fig. 10). When the immune bellets 
I 
of anti-HRI mAb F were washed 5 times with TBS followed by blotting with 432! anti-
hsp90/hsp70 polyclonal antibody, hsp90 was found to be co-adsorbed with HRI (Fig. 
1 lA). A reduction in the amount of hsp90 associated with HRI was observed in anli-HRI 
F immunoprecipitates prepared from heme-deficient lysates as compared to those prlpared 
from heroin-supplemented lysates (Fig. 1 lA). Although the amount of hsp90 assdciated 
with HRI in heme-deficiency from different lysates varies somewhat, reduction in the 
association of HRI with hsp90 is always observed in heme-deficient lysates (data not 
shown). To verify the association of HRI with hsp70, the immune pellets prepared using 
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the anti-HRI mAb F must be washed with TBS containing 0.1 % SDS, 1 % DOC, and 1 % 
Triton X-100 to remove the non-specifically bound of hsp70 (data not shown). ,estern 
blot analysis of the detergent washed anti-HRI pellets with a mixture of the N27 and C92 
anti-hsp70 mAbs, showed that hsp70 was co-adsorbed specifically with HRI (Fig. l lB). 
More hsp70 appeared to be associated with HRI adsorbed from heme-deficient lysates than 
from hemin-supplemented lysates (Fig. 1 JB). We were unable to determine whef er the 
ECl antigen was co-adsorbed with HRI from hemin-supplemented lysates by the anr· -HRI 
mAb F. Since HR! is present in lysates in low abundance, the inability to detect !e co-
adsorbed ECl antigen may be because the amount of this protein was under the dejection 
limits of Western blotting with the ECI mAb. For example, using the 4322 anti-
hsp90/hsp70 polyclonal antiserum, the association of hsp90 with HRI in the immunj pellet 
of the anti-HRI mAb F from hemin-supplemented reticulocyte lysates was readily delected. 
However, it was not detectable if the AC88 anti-hsp90 mAb was used. 
Discussion 
The interactions of the heme-regulated eIF-2a kinase with hsp90, hsp70, and the 
ECl antigen in rabbit reticulocyte lysates have been examined. The results indicale that 
HRI exists in the lysates as a multiprotein complex with heat shock proteins. Thl HRI-
HSPs complex consists of at least four components, HRI, hsp90, hsp70, and thl ECl 
antigen. The formation or stability of this complex is dependent upon the presehce of 
hemin at a concentration of at least 5 µM. A hemin concentration of 5 µMis the mif mum 
concentration sufficient to saturate the heme binding sites on partially purified Hjl and 
inhibit its activation (Fagard and London, 1981). The interaction of HRI with hsp90 and 
the ECl antigen is regulated by hemin, while the interaction of HRI with hsp70 is not 
hemin-dependent, suggesting that hsp90 and hsp70 may bind to HRI at different sites. The 
anti-HRI mAb F co-adsorbed more hsp70 with HRI from heme-deficient than from Jemin-
supplemented lysates. However, it is not certain at this time whether this apparent · crease 
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in the binding of hsp70 to HRI in heme-deficient lysates is specific, since an increase in the 
association of hsp70 with non-immune control pellets was observed in heme-dJicient 
lysates. The observation that hsp90 could bind back to HRI in heme-deficient lysltes, if 
hemin was added to the adsorption buffer, suggests that there is a dynamic equiliblum in 
the association of HRI with hsp90. This equilibrium favors the formation of HRI1hsp90 
complex, if hemin is present. 
The Western blot analysis of the immune pellets prepared using the 8D3 antitsp90 
mAb indicated that the ECl antigen and hsp70 could be co-adsorbed with hsp90 frof both 
heme-deficient and hemin-supplemented lysates (Fig. 5A and 5B). The observatiohs that 
the interaction of the EC! antigen with HR! is dependent upon the presence of he+, but 
the association of the ECl antigen with hsp90 is not hemin dependent, suggests trt the 
interaction of the ECl antigen with HRI may be mediated through its associatior with 
hsp90. The interaction of the ECl antigen with steroid hormone receptors via hsp90 has 
been proposed (Renoir et al., 1990). However, the actual mechanism through whf h the 
ECl antigen interacts with HRI remains to be characterized. The observation that only 
about 50 to 70% of the ECl antigen in reticulocyte lysate could be co-adsorbed with hsp90 
by the 8D3 anti-hsp90 mAb from either heme-deficient or hemin-supplemented ]ysates 
(data not shown), suggests that not all ECl antigen associates with hsp90 in rabbit 
reticulocyte lysates. Also some dissociation of the ECl antigen from hsp90 may occur 
over the time course of the experiment, if there are less stable complexes of the hsp90-EC1 
antigen in lysates. Western blot analysis of the immune pellets prepared using thr EC! 
mAb showed that hsp70 associates with the ECl antigen whether hemin is present in 
reticulocyte lysates or not. These observations suggest that a complex containing hsp90, 
hsp70, and the ECl antigen is present in reticulocyte lysate, and that the formation bf this 
complex is not dependent on the presence of hemin. 
The fact that the 8D3 anti-hsp90 and the ECl mAbs are able to adsorb HRI, early 
quantitatively from hemin-supplemented reticulocyte lysates suggests that these proteins are 
27 
present in a complex with a minimum stoichiometry of 1:1:1 (HRl:hsp90:EC1 antigrn). It 
is difficult to show the stoichiometry of hsp70 in the HRI-HSPs complex at this time, since 
we currently do not have an anti-hsp70 mAb available which is capable of quantitltively 
adsorbing hsp70 from reticulocyte lysates. 
Two other proteins with molecular weights of approximately 100 and 60 kDa were 
also reported to be associated with hsp90 in rabbit reticulocyte lysates (Matts et al., 1992). 
This is consistent with the observation that hsp90 exists in the cytosol of Hepa cell extracts 
in heteromeric complexes with proteins that have molecular weights similar to those 
described here (Perdew and Whitelaw, 1991). However, the functions of these p:Foteins 
within the hsp90 heteromeric complex have not yet been characterized. A recent repbrt has 
shown that the reconstitution of purified avian progesterone receptor with hsp90 in rabbit 
reticulocyte lysate occurs in conjunction with the reassociation of the receptor with several 
proteins, including hsp70, the ECl antigen, and a 60 kDa protein (p60) (Smith et al., 
1990). Since no one has been successful in reconstituting the binding of purified steroid 
hormone receptors to purified hsp90 in vitro, it has been suggested that one or Jore of 
these hsp90-associated proteins may be involved in the assembly of steroid horone 
receptor-hsp90 complexes (Smith et al., 1990; Scherrer et al., 1990). Because of tr low 
abundance of HRI in reticulocyte lysates, we are unable to determine directly whethtr HRI 
interacts with the 60 kDa protein described above, although we have observed thaJ about 
5% of the HRI from hemin-supplemented reticulocyte lysate was co-adsorbed with the 60 
kDa protein by an anti-p60 mAb (data not shown). 
The major heat shock proteins have been proposed to act as molecular chaperones 
(Schlesinger, 1990; Ellis and van der Vies, 1991; Gething and Sambrook, 1992). The 
functions of the various heat shock proteins is currently being studied intensely. The 
interaction of hsp90 with a number of protein kinases has been reported to affeat their 
activities (Matts and Hurst, 1989; Rose et al., 1989; Szyszka et al., 1989; Nygard et al., 
1991; Miyata and Yahara, 1992). Several oncogene products with tyrosine kinase activity 
are reported to associate with hsp90 upon their biosynthesis (Brugge et al., 1981; 
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Ziemiecki et al., 1986). Activation of the tyrosine kinase activity of pp6ov-src requrres its 
dissociation from hsp90 and insertion into the plasma membrane (Brugge et al., 1981; 
Brugge, 1986). The glucocorticoid receptor (GR) is recovered from hormone-free cells as 
a heteromeric complex containing hsp90 (Pratt, 1990). When GR is bound to hspJO, it is 
maintained in a high-affinity steroid binding conformation, which does not bin;I DNA. 
Binding of hormone results in the dissociation of hsp90 and associated proteins Ld the 
aquisition of high affinity DNA binding activity (Sanchez et al., 1987; Bresnick et al., 
1989; Dalman et al., 1989; Scherrer et al., 1990). Hsp90 has been found to bijd and 
protect casein kinase II from self-aggregation and enhance its kinase activity (Miyata and 
Yahara, 1992). Hsp90 apparently associates with HRI, keeping HRI in an inactive fbrm in 
the presence of hemin. Recently, Matts and Hurst found that the ability of hemin to rs tore 
protein synthesis in heme~deficient lysates correlated with the levels of hsp90 resent 
(Matts and Hurst, 1992). In all these cases, hsp90 appears to regulate the function ofi target 
proteins by forming complexes with the proteins. 
The ECl antigen, which participates in the heterooligomeric form of steroid 
receptors in association with hsp90 (Tai et al., 1986; Renoir et al., 1990), has been rjcently 
identified as a novel heat shock protein, hsp56 (Sanchez, 1990). The clonijg and 
sequencing of the gene suggest that the EC! antigen may bind ATP and calmodu+, and 
that it may also belong to the peptidylproline cis-trans isomerase (PPI) protein family 
(Lebeau et al., 1992). Consistent with this proposal, the ECl antigen haJ been 
demonstrated to bind the immunosuppressant FK506 (Callebaut et al., 1992; Yem et al., 
1992; Tai et al., 1992) and calmodulin (Massol et al., 1992). The association of HRI with 
the ECl antigen implies that the polypeptide structure and function of HRI .Jay be 
modulated by the PPI activity of the ECl antigen. 
The 70 kDa heat shock proteins interact with other proteins and maintain r alter 
their conformational states (Morimoto et al., 1990; Pelham, 1990; Gething and Sambrook, 
1992). They have been shown to participate in protein folding, translocation of p loteins 
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across membranes, and assembly or disassembly of oligomeric protein com! lexes 
(Pelham, 1990; Wickner et al., 1991). Among proteins that are known to intera It with 
hsp70 are a number of cellular and viral proteins such as SV40 large T antigen, p i1yoma 
virus middle T antigen, mutant forms of the cellul~ anti~nc~ge~e protein p53, reroid 
hormone receptors, and heat shock factors (HSF) (Pmhas1-Kims1 et al., 1986; Hinds et 
al.,1987; Walter et al., 1987; Clarke et al., 1988; Kost et al., 1989; Pallas et al., 1989; 
Sawai and Butel, 1989; Smith et aJ., 1990; Hainut and Milner, 1992; Abravaya et al., 
1992). The data presented here demonstrate that hsp70 associates with HRI and this 
. I 
intera~ti~n, unlike hsp~O, is not .hemin.~epend~nt.. The f~nction~l significance of these 
assocrnnons of HRI with hsps, m add1t1on to its mteracuons with hsp90 and th~ ECl 
antigen, remains to be established. 
Figure 4. The Ability of the 8D3 Anti-hsp90 mAb to Remove Hsp90 from Rabbit 
Reticulocyte Lysates. 
Proteins from 2.5 µl of hemin-supplemented protein synthesis mixes were 
adsorbed with non-:immune control (C) or 8D3 anti-hsp90 ([) mAb bound to 
GAM-agarose as described under "Experimental Procedures". Non-
adsorbed (Sup) and adsorbed (Pe[) fractions were immunoblotted with the 
4322 anti-hsp90/hsp70 antibody to detect the presence of hsp90. L, 2.5 µl 
of unincubated whole protein synthesis mix. 
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Figure 5. Effect of Hemin Concentration on tbe Coadsorption of HRI and Hsp90. 
Proteins from 2.5 µI of hemin-supplemented ( +H) and heme-deficient (-H) 
protein synthesis mixes were adsorbed with the non-immune control (C) or 
803 anti-hsp90 (/) mAb bound to GAM-agarose in the presence of TB 
containing 20, 5, or O µM hemin as described under "Experimental 
Procedures". Non-adsorbed (Sup) and adsorbed (Pel) fractions were 
immunoblotted for the presence of HRI. S, purified HRI standard; HC, 
heavy chain of IgM. 
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Figure 6. Coadsorption of the ECl Antigen and Hsp70 with Hsp90 by the 8D3 Anti-
hsp90 mAb. 
Proteins from 2.5 µI of hemin-supplemented ( +H) and heme-deficient (-H) 
protein synthesis mixes were adsorbed by control non-immune (C) or 8D3 
anti-hsp90 ([) mAb in the presence of TB, as described under "Experimental 
Procedures". Proteins in the immunoprecipitates were extracted directly with 
SDS sample buffer for Western blotting with the ECl mAb (Panel A); or 
proteins were extracted with TB/500, as described under "Experimental 
Procedures", followed by denaturation with SDS sample buffer for Western 
blotting with the N27 and C92 anti-hsp70 mAbs (Panel B). S, 
immunoaffinity purified ECl antigen (p59) from rabbit uterine cytosol; L, 
1.25 µ1 of unincubated whole reticulocyte lysate; 56 and 52 kDa, the 
estimated molecular masses of the ECl antigen and a lower molecular mass 
protein that reacts with the ECl mAb; HC, heavy chain oflgM. 
-- ----------
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Figure 7. The Ability of the ECl rnAb to Remove the ECl antigen from Rabbit 
Reticulocyte Lysates. 
Proteins from 2.5 µ1 of hemin-supplemented protein synthesis mixes were 
adsorbed with the non-immune control (C) or the ECl rnAb (/) bound to 
GAG-agarsoe in the presence of TB containing 20 µM hemin as described 
under "Experimental Procedures". Non-adsorbed (Sup) and adsorbed (Pe[) 
fractions were immunobloted with the ECl rnAb for the presence of the 
ECl antigen. L, 1.25 µl of unincubated whole reticulocyte lysate; 56 kDa, 
the estimated molecular mass of the ECl antigen; ECJ, the ECl antigen; 









Figure 8. The Ability of the ECl mAb- to Immunoadsorb HRI from Reticulocyte Lysates. 
Proteins from 2.5 µl of hemin-supplemented ( +lf) and heme-deficient (-lf) 
protein synthesis mixes were adsorbed with non-immune control (C) or 
ECl ([) antibody bound to GAG-agarose in the presence of TB as described 
under "Experimental Procedures". Nonadsorbed proteins (Sup) and 
adsorbed proteins (Pel) were Western blotted for the presence of HRI. HC, 
heavy chain of IgG. 
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Figure 9. Coadsorption of Hsp90 and Hsp70 with the ECl Antigen by the ECl mAb. 
Proteins from 2.5 µl of hemin-supplemented ( +H) and heme-deficient (-H) 
protein synthesis mixes were adsorbed with non-immune control (C) or 
ECl (/) antibody bound to GAG-agarose in the presence of TB, as 
described under "Experimental Procedures". Adsorbed proteins (Pel) were 
Western blotted with the AC88 anti-hsp90 mAb to detect the presence of 
hsp90 (Panel A) or a combination of N27 and C92 antibodies to detect the 
presence of hsp70 (Panel B). HC, heavy chain of lgG. 
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Figure 10. The Ability of the Anti-HRI mAb F to Remove HRI from Rabbit Reticulocyte 
Lysates. 
Proteins from 10 µl of hemin-supplemented ( +H) and heme-deficient (-H) 
protein synthesis mixes were adsorbed with non-immune control (C) or the 
anti-HR! (/) antibody bound to GAG-agarose in the presence of TBS, as 
described under "Experimental Procedures". Nonadsorbed proteins (S) and 
adsorbed proteins (P) were Western blotted with the anti-HR! mAb F for 
the presence of HRI. HC, heavy chain of IgG. 
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Figure 11. Coadsorption of Hsp90 and Hsp70 with HRI by the Anti-HRI mAb F. 
Proteins from 10 µl of hemin-supplemented ( +H) and heme-deficient (-H) 
protein synthesis mixes were adsorbed with non-immune control (C) or the 
anti-HRI (/) antibody bound to GAG-agarose in the presence of TBS, as 
described under "Experimental Procedures". The.adsorbed proteins were 
Western blotted with the 4322 anti-hsp90/hsp70 (Panel A) or with the N27 
and C92 anti-hsp70 (Panel B) antibodies to detect the presence of hsp90 and 
hsp70, respectively. HC, heavy chain of IgG. 
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CHAPTER III 
HEAT SHOCK PROTEINS REGULATE HRI ACTIVITY 
Introduction 
Protein synthesis in reticulocytes and their lysates is dependent on the preslnce of 
hemin (Bruns and London, 1965; Zucker a:nd Schulman, 1968; Hunt et al., 1972; 
Adamson et al., 1969). In heme-deficiency, protein synthesis is inhibited at the 1 vel of 
initiation due to the activation of a heme-regulated inhibitor (HRI) (Howard et al.l 1970; 
Maxwell et al., 1971; Pain, 1986; London et al., 1987). HRI is a cAMP-indepbndent 
protein kinase, which specifically phosphorylates the 38 kDa a-subunit of the euk~yotic 
initiation factor eIF-2 (eIF-2a) (Levin et al., 1976; Farrell et al., 1977). Phospho I lation 
of eIF-2a in reticulocyte lysates results in the binding and sequestration of the re ersing 
factor (RF) in an inactive RF-eIF-2a(P) complex (Amesz et al., 1979; Siekierk et al., 
1982; Matts et al., 1983). The unavailability of RF, which is required for the exch nge of 
GTP for GDP bound to eIF-2 in the recycling of eIF-2, results in the shut-off of • rotein 
synthesis (Matts et al., 1983; Panniers and Henshaw, 1983; Matts and London, 1984; 
Siekierka et al., 1984; Thomas et al., 1984; Matts et al., 1986). 
Inhibition of protein synthesis also occurs in heroin-supplemented reticf ocyte 
lysates in response to a variety of stress conditions, such as addition of oxidants ld heat 
shock (Hunt, 1979; London et al., 1987; Jackson, 1991). These stress co~ttions 
commonly induce the heat shock or stress response in cells, which is characterized by 
transcriptional activation of heat shock genes, translational inhibition of normal trotein 
synthesis, and selective translation of the mRNAs coding for heat shock p oteins 
(Lindquist and Craig, 1988; Schlesinger, 1990; Morimoto et al., 1990; Ang et al.j 1991; 
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Sorger, 1991; Hightower, 1991; Morimoto et al., 1992). The inhibition of normal protein 
synthesis in response to heat shock in HeLa and Ehrlich ascites cells correlates +th the 
activation of an eIF-2a kinase with antigenic properties similar to those of HRI (!Duncan 
and Hershey, 1984; DeBenedetti and Baglioni, 1986; Scorsone et al., 1987). However, 
the mechanism for the activation of HRI in response to these stress conditions is unclear. 
It has been widely accepted that heat shock proteins play important roles ij living 
I 
organisms. The synthesis of hsps is induced in cells in response to a variety of 
environmental and pathophysiological stresses (Craig, 1985; Lindquist, 1986).j Most 
agents or conditions that induce the heat shock response cause the accumula ion of 
denatured and oxidized proteins (Lindquist and Craig, 1988; Craig, 1991). The 1Le1 of 
hsp70 produced correlates quantitatively with the degree of stress, and the accumulJrion of 
specific quantities of hsp70 must occur before the transcription of hsp mRNAs is reJressed 
(DiDomenico et al., 1982; Mizzen and Welch, 1988; Morimoto et al., 1992). SimilJly, the 
accumulation of specific amounts of hsp70 must also occur before normal protein ,+thesis 
recovers in heat shocked cells (DiDomenico et al., 1982; Mizzen and Welch, 1988; Laszlo, 
1988). The development of resistance to stress-induced translational inhibition in Sri essed 
cells also correlates with the levels of hsp70 present in the cells (Mizzen and Welch 1988; 
Laszlo, 1988). These observations suggest that hsp70 may function as a cellular 
thermometer and regulate the heat shock response in cells. However, the molecular events 
that lead to the arrest and recovery of normal protein synthesis in response to heat shock 
and other stresses are still a mystery. 
Recently, we have demonstrated that HRI interacts with hsp90, hsp70, and tie ECl 
antigen (hsp56) in rabbit reticulocyte lysates (Matts and Hurst, 1989; Matts et al., 1992). 
The association of HRI with hsp90 and the ECl antigen is dependent upon the pres, nee of 
hemin in lysates, while the intemction of HRI with hsp70 is not heroin-dependent (1atts et 
al., 1992). Furthermore, the levels of hsp90 present in the lysates were found to clrrelate 
with the ability of hemin to restore protein synthesis in heme-deficient lysates, wliile the 
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sensitivity of HRI to activation in response to heat or oxidative stress varied inversdy with 
the levels of hsp70 present in lysates (Matts and Hurst, 1992). These findings pJmpted 
us to propose that the interaction of hsp70 with HR! maintains HR! in an if active 
conformation and heat shock causes to the accumulation of denatured proteins whio:h bind 
to hsp70, resulting in the activation of HRI. This model predicts that: addition of detatured 
proteins should activate HRI and inhibit protein synthesis in hemin-supplemented 1lysates; 
denatured proteins should bind to hsp70 and block the binding of hsp70 to HRI; ald heat 
shock should block the interaction of hsp70 with HRI. 
The data presented here indicate that: (1) it is the heat shock cognate hsc70 which 
binds to HRI; (2) release of hsc70 from HRI is dependent on ATP hydrolysis; (3) 
activation of HRI in heme-deficient lysates correlates with the alteration of the le~els of 
hsp70 bound to HRI; (4) addition of denatured proteins, not native ones, inhibits protein 
synthesis in hemin-supplemented lysates; (5) the denatured proteins bind and seiuester 
hsp70, prevent the association of hsp70 with HRI, and activate HRI; (6) heat shocklblocks 
hsp70 interaction with HRI and activates HRI; and (7) addition of oxidants, suctt as N-
ethylmaleimide (NEM) and heavy metal ions (Hg++), activates HRI through a plrhway 
differing from those of denatured proteins and heat shock. 
Experimental Procedures 
Materials 
Goat anti-mouse IgM and IgG were obtained from Jackson Immunoresearch 
Laboratories. Bovine serum albumin (fraction V) (BSA), bovine ~-lactoglobulin 1 (LG), 
bovine a-lactaburnin (LA), rabbit anti-bovine serum albumin, apyrase (grade VIIII), N-
ethylmaleirnide (NEM), nitro blue tetrazolium, 5-bromo-4-chloro-3-indolyl phospliate, p-
nitrophenyl-agarose, mouse IgM (TEPC 183), and mouse IgG (MOPC 21) were otained 
from Sigma. Alkaline phosphatase conjugated to rabbit anti-mouse IgG or to golr anti-
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rabbit IgG was obtained from ICN. L-[14C]Leucine (340 mCi/mmol) and [y-32f1ATP 
(1000-3000 Ci/mmol) were obtained from Du Pont-New England Nuclear. The 8D3 anti-
hsp90 IgM monoclonal antibody (mAb) (Perdew, 1988; Perdew and Whitelaw, 1911) was 
provided by Dr. Gary Perdew (Purdue University); the AC88 anti-hsp90 IgG mAb (Riehl 
et al., 1985) was provided by Dr. David Toft (Mayo Clinic, Rochester, M 
KN382/EC1 IgG mAb (ECl) (Tai et al., 1986) was provided by Dr. Lee Faber ( 
College of Ohio, OH); the N27F3-4 (N27) and C92F3A5 (C92) anti-hsp70 IgG mAbs 
(Kost et al., 1989; Welch and Suhan, 1986) were provided by Dr. William elch 
(University of California, San Francisco); the anti-HRI F IgG mAb (Pal et al., 19 1) was 
provided by Dr. J.J. Chen (Massachusetts Institute of Technology); and the rabbit 4322 
anti-hsp90/hsp70 polyclonal antiserum (Erhart et al., 1988) was provided by Dr. Stephen 
J. Ullrich (National Cancer Institute). 
Buffers 
TB, 10 mM Tris-HCl (pH7.5); TB/50, 10 mM Tris-HCI (pH 7.5) contai ing 50 
mM NaCl; TBS, 10 mM Tris-HCI (pH 7.5) containing 150 mM NaCl; TB/500, 0 mM 
Tris-HCI (pH 7.5) containing 500 mM NaCl; TBS/5% NFDM, TBS containing 5 r (w/v) 
non-fat dry milk; 4X Sample Buffer, 250 mM Tris-HCI (pH 6.8) containing 16~ (v/v) 
glycerol, 5% (w/v) SDS , 0.01 % (w/v) bromophenyl blue (BPB), and 0.055% (w/v) 
dithiothreitol (DTT) (fresh OTT was added just before use). 
Protein Synthesis and eIF-2a Phosphm:ylation in Reticulocyte Lysates 
Reticulocyte lysates were prepared from anemic rabbits as described prejiously 
(Hunt et al., 1972), using buffered saline containing 5 mM glucose to w sh the 
reticulocytes prior to their lysis (Matts et al., 1991). Protein synthesis was meas red by 
the incorporation of [ 14C]leucine into acid precipitable protein at 30 °C in stlndard 
reticulocyte reaction mixtures (Hunt et al., 1972; Ernst et al., 1978). Hemin-supplerbented 
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control lysates contained 20 µM hemin-HCI. Protein synthesizing lysates were pulsed with 
[y-32P]ATP (0.5 mCi/µl protein synthesis mix final concentration) for 4 min at thl times 
indicated in the figures, and 2.5 µl aliquots were analyzed by 8% SDS-PAGE as delcribed 
(Matts et al., 1991). 
Preparation of Denatured Proteins 
Bovine serum albumin (BSA) was carboxymethylated with iodoacetic acid and 
bovine P-lactoglobulin A (LG) was carboxyamidomethylated with iodoacetatde as 
described previously (Ananthan et al., 1986). The reduced carboxymethylate<i:l BSA 
(RCM-BSA) and the reduced carboxyamidomethylated-LG (RCAM-LG) wet then 
extensively dialyzed over a 72 hours period against six 2 liter volumes of 10 mM Tts-HCI 
(pH 7.6) containing 150 mM NaCl (TBS) and stored in aliquots at -70 °C. Solutions of the 
native proteins (-10 mg/ml) were prepared fresh in TBS prior to use. 
Immunoprecipitation 
p-Nitrophenyl-agarose was rinsed free of isopropanol, and was coupled to goat 
anti-mouse IgG (GAMG), or goat anti-mouse IgM (GAMM), or goat anti-rab,it lgG 
(GARG) as described previously (Matts et al., 1992). The preparations contained 
approximately 1.6 mg of antibody coupled per ml of packed agarose. GAMG-alarose, 
I 
GAMM-agarose, and GARG-agarose were used as a 1: 1 slurry in TBS. The following 
general procedure describes the quantities of antibodies that were determined quant+tively 
to adsorb hsp90, the ECl antigen, HRI, BSA or RCM-BSA from 10 µI of reticulocyte 
lysate protein synthesis mix: for the adsorption of hsp90, 8D3 anti-hsp90 mAb frob 62.5 
µl of ascites fluid was bound to 87 .5 µl of GAMM-agarose; for the adsorption of tJe ECl 
antigen, 62.5 µI of ECl mAb (2.8 mg/ml) was bound to 100 µl of GAMG-agarose; for the 
adsorption of HRI, anti-HR! mAb F from 15 µl of anti-HR! mAb F ascites fluid was 
bound to 25 µI of GAMG-agarose; for the adsorption of BSA or RCM-BSA, 7f> µ1 of 
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rabbit anti-BSA antiserum was bound to 75 µl of GARG-agarose. Non-immune control 
incubations contained equivalent volumes of TEPC 183 mouse IgM or MOPC 21 mouse 
IgG ascites with a concentration of approximately 5 mg of antibody per ml, or a rabbit pre-
immune antiserum. 
Antibodies were bound to the GAMG-, or GAMM-, or GARG-agarose lor two 
hours on ice. The GAMG-, or GAMM-, or GARG-agarose was then washed seqmmtially 
with 500 µl each of: TBS, TB/500; TBS; and adsorption buffer (either TBS or TB as 
indicated in the legend of the figures). The GAMG-, or GAMM-, or GARG-agarTe was 
pelleted by a 10 sec centrifugation (full speed burst) in a Brinkman model 5415 Microfuge. 
The adsorption buffer contained 20 µM hemin-HCl for the immunoadsorption of p~oteins 
from hemin-supplemented protein synthesis mixes. Rabbit reticulocyte lysatel were 
incubated under standard conditions for protein synthesis (Hunt et al., 1972; Ernsl et al., 
1978): in the presence (hemin-supplemented lysates) or absence (heme-deficient lyslres) of 
20 µM hemin; in the presence or absence of 25 µM BSA or RCM-BSA in hemin 
supplemented lysates; in the presence of 25 µM Hg++ or 20 µM NEM in fu.emin-
supplemented lysates for 20 min at 30 °C; or in the presence of 20 µM hemin-HCl for 20 
min at 42 °C. The protein synthesis mixes were then treated with or without apyrase (one 
unit of apyrase per 10 µl of protein synthesis mix) on ice for 15 min. Apyrase trelatment 
was found to be necessary for Stabilization of hsp70-protein complexes (Beckmant et al., 
1990; Palleros et al., 1991; Matts et al., 1992). After the removal of excess ads©rption 
buffer from the GAMG-, or GAMM-, or GARG-agarose pellets containing the bound 
antibodies, 10 µl of protein synthesis mixes were added directly for the adsorpfion of 
hsp90, the ECl antigen, HRI, BSA or RCM-BSA, and their associated proteins. S~mples 
were incubated at 4 °C for 90 min with continuous mixing. The samples were then ~iluted 
10-fold with 90 µl of adsorption buffer, and the non-adsorbed proteins (supematantL were 
I 
separated from the proteins adsorbed to the agarose (pellets) by centrifugation. ]or the 
analysis of hsp70 associated with HRI, it was necessary to dilute the protein synthesis 
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mixes 10-fold with adsorption buffer prior to the 90~min adsorption of the prot~ins, to 
reduce the nonspecific binding of hsp70. 
The pellets were then washed five times with 500 µl of the buffers described below 
to remove nonadsorbed proteins. For the adsorption of hsp90 or the ECl antigt, and 
their associated proteins with the 8D3 anti-hsp90 or the EC! mAbs, the pell+ were 
washed sequentially: once with TB, twice with TB/50, and twice with TB. }or the 
adsorption of HRI, BSA or RCM-BSA and their associated proteins with the anti-HRI 
mAb For the rabbit anti-BSA antiserum, the pellets were washed five times with TBS. 
For the analysis of hsp70 associated with HRI, the pellets were washed sequentiallt: once 
I 
with TBS, three times with TBS containing 1 % sodium deoxycholate, 1 % Triton iX-100, 
I 
and 0.1 % SDS, and once with TBS. Pellets were diluted with an equal volume of water, 
and stored at -70 °C prior to analysis. Samples were prepared for SDS-PAGE by the 
addition of one volume of 2XSDS sample buffer followed by heating in a boiling water 
bath for 2.5 min. 
Western Blot Analysis 
Samples were separated by SOS-PAGE in 10% or 8% gels (9x14x0.15 cm; 37.5:1 
acrylamide:Bis) for analysis (as noted in the figure legends), and proteins were transferred 
to a PVDF membrane (Biorad) at a current density of 2.5 mA/cm2 for 40 min for Jestern 
blot analysis as described previously (Matts and Hurst, 1989; Matts et al., 1992). Blots 
were blocked with TBS/5% NFDM for one hour at room temperature. The primary 
antibody was then reacted with the blots at 4 °C overnight. Blots were washed twiJe with 
I ·. 
TBS containing 0.5% Tween-20, once with TBS, and then blocked with TBS/5% NFDM 
prior to reaction with alkaline phosphatase-conjugated rabbit anti-mouse IgG or golt anti-
rabbit IgG (diluted 1:1000 in TBS/1 % NFDM) for two hours at room temperature. Blots 
were washed twice with TBS containing 0.5% Tween-20, and twice with TBS. Proteins 
were then detected by incubating blots in alkaline phosphatase reaction buffer (1 10 mM 
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Tris-HCI, pH9.5, containing 100 mM NaCl, 100 mM Mg(OAch, 300 µg/ml NTB and 150 
µg/ml BCIP) at 35 °C for 1 to 5 min. 
For detecting HRI, the ascites fluid containing the anti-HR! mAb F was ciiluted 
1:250 in TBS/1 % NFDM. For detecting hsp90, the 4322 anti-hsp90/hsp70 antiserlm was 
diluted 1:50 in TBS/1 % NFDM. For detecting hsp70, the N27 anti-hsc73/hsp 72 m1lb was 
diluted 1:1000 in TBS/1 % NFDM. For detecting the ECl antigen, the ECl m b was 
diluted 1:1000 in TBS/1 % NFDM. 
Reconstitution Reactions 
Hemin-supplemented reticulocyte lysates were incubated under standard conditions 
for protein synthesis (Hunt et al., 1972; Ernst et al., 1978) at 30 °C (control) or 42 °~ (heat 
shock) for 20 min. The protein synthesis mixes were then treated with apyrale at a 
concentration of one unit of apyrase per 10 µl of protein synthesis mixture to stabJize the 
hsp70-protein complexes. The HRI-free reconstitution reaction supernatants (conJol and 
heat shocked) were prepared by quantitatively removing HRI with the anti-HR! mAJ F, but 
with no apyrase treatment. For reconstitution, HRI was then immunoprecipitateh from 
these apyrase treated lysates by the anti-HR! mAb Fas described above. After ~ashing 
with TBS five times, the HRI immune pellets were then incubated with the reconstitution 
reaction supematants as described in the legends of the figures. The reconsttution 
reactions were carried out at 30 °C for 5 min. The pellets were then washed twioe with 
TBS, three times with TBS containing 1 % DOC, 1 % Triton 100, and 0.1 % SOS, and 
twice with TBS. The adsorbed proteins were then extracted into SOS-PAGE sampll buffer 
and separated on a 10% SOS-PAGE gel followed by Western blot analysis as described 
above. The HRI-associated hsp70 was then detected by the N27 anti-hsp70 mABj or the 
4322 anti-hsp90/hsp70 serum. 
Results 
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The constitutively expressed form of hsp70 (hsc73) interacts with HRI. 
The N27 anti-hsp70 monoclonal antibody (mAb) is able to recognize both hsc73, 
the constitutively expressed form of hsp70, and hsp72, the inducible form of hsp70, 
respectively (Kost et al., 1989). However, the C92 anti-hsp70 mAb can recognize only 
hsp72 (Welch and Suhan, 1986). By using the. C92 and the N27 anti-hsp70 mA,s, both 
hsc73 and hsp72 were found to be present in the rabbit reticulocyte lysates by West~m blot 
analysis (Fig. 12). When the immune pellets of the anti-HRI mAb F were analyzej by the 
C92 mAb, no hsp70 band was observed to be coadsorbed with HRI (Fig.l12A). 
However, when the immune pellets were analyzed by the N27 mAb, a hsp70 ba d was 
clearly observed to be coadsorbed with HRI from both hemin-supplemented and heme-
deficient reticulocyte lysates (Fig. 12B). The immunological properties of the hsp710 band 
coadsorbed with HRI indicates that the constitutively expressed form of hsp70 is assbciated 
with HRI in reticulocyte lysates. More hsc73 was observed to associate with HJI from 
heme-deficient lysates than that from hemin-supplemented lysates (Fig. 12B). 
The Release of Hsp70 from HRI Is Dependent upon ATP-Hydrolysis. 
Hsp70 binds to ATP and has a weak ATPase activity (Zylicz et al., 1983; Welch 
and Feramisco, 1985). Release of hsp70 from its substrates is dependent on ATP-
hydrolysis (Pelham, 1986; Clarke et al., 1988; Flynn et al., 1989; Kost et al., 1989; 
Beckmann et al., 1990; Palleros et al., 1991). These observations prompte I us to 
determine whether the release of hsp70 from HRI requires the hydrolysis of ATI. HRI 
was immunoprecipitated from hemin-supplemented and heme-deficient lysates by t1e anti-
HRI mAb F. The immunoprecipitates were then incubated with TBS containing 5 mM 
Mg++ or TBS containing 5 mM Mg++ and 1 mM ATP. Western blot analysis indica ed that 
hsp70 dissociated from hsp70-HRI complexes when ATP was present in the incJbation 
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buffer, while no hsp70 was released of from HRI-hsp70 complexes if no ATP was present 
in the incubation buffer (Fig. 13). 
Changes in the Levels of Hsp70 Associated with HRI During Activation of HRI in Heme-
Deficiency. 
In heme-deficiency, HRI is activated and protein synthesis shuts off after 5 min of 
incubation (Fig. 15). Both hsp90 and the ECl antigen disassociate from HRI in heme-
deficient reticulocyte lysates, while hsp70 remains bound to HRI (Matts et al., 199
1
2). To 
understand the behavior of hsp70 during the process of HRI activation in heme-deficient 
lysates, the interaction of HR! with hsp70 was examined after various times of inc+ation. 
The amount of hsp70 coadsorbed with HRI was observed to vary with the incubaticm time 
(Fig. 14). The highest amount of hsp70 was observed to be associated with HRI Jrior to 
the incubation of the heme-deficient lysates (0 min) (lane 2); little hsp70 was observjd to be 
associated with HRI after 5 min of incubation (lane 3); after 10 min of incubatiln, the 
amount of hsp70 associated with HRI increased (lane 4); no further increase in the lmount 
of hsp70 bound to HRI was observed after 15 min of incubation (lanes 5 & 6j, The 
amount of hsp70 coadsorbed with HRI (Fig. 14) was quantitated by scanning of Jestem 
blots with the Discovery Series TM POI Densitometer (Model DNA 35) (Table I ahd Fig. 
15). We noted that protein synthesis in heme-deficient lysates shut off after 5 min 
incubation at 30 °C, the time at which little hsp70 was bound to HRI. 
Denatured Proteins Sequester Hsp70 Causing the Activation of HRI. 
Denatured Proteins Inhibit Protein S nthesis in Rabbit Reticuloc te L, sates. 
I 
Ananthan et al. (1986) reported that microinjection of denatured proteins, RCM-BSA or 
RCAM-LG, into frog oocytes triggered the activation of heat shock genes. Rlduced 
carboxymethylated bovine a-lactabumin (RCM-LA) has been used as a model subs~ate to 
I 
study the interactions of hsp70 with proteins in vitro (Palleros et al., 1991). Thee feet of 
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denatured proteins on protein synthesis in hemin-supplemented reticulocyte lysates was 
examined. Protein synthesis in hemin-supplemented lysates was inhibited by the rition 
of the denatured proteins (RCM-BSA, RCM-LA, and RCAM-LG), while little or no 
inhibitory effect of the native proteins was observed (Fig. 16A). The concentratons of 
RCM-BSA, RCM-LA and RCM-LG that inhibited protein synthesis by 50% relative to the 
control (IC50) were estimated to be 27, 23 and 17 µM, respectively (Fig. 16B). 
Denatured Proteins Activate HRI in Hemin-supplemented Lysates. The capacity of 
I 
lysate to phosphorylate eIF-2a in situ was examined to determine whether the inhibition of 
protein synthesis in hemin-supplemented reticulocyte lysates caused by the additiof of the 
denatured proteins was due to the activation of HRI. An increase in eIF-2a 
phosphorylation in the lysates containing the 25 µM RCM-BSA was observed, while no 
increase in eIF-2a phosphorylation above the control was observed in lysates coJaining 
25 µM native BSA (Fig. 17). The increase in eIF-2a phosphorylation caused by the 
RCM-BSA was suppressed by the anti-HRI mAb F (Fig. 17). Similarly, RCM-ILA and 
RCM-LG, but not native LA or LG, also stimulated eIF-2a phosphorylation (dlta not 
in hemin-supplemented lysates. 
Denatured proteins bind hsp70 and seguester hsp70 from HRI. The obse ations 
that the sensitivity of protein synthesis to stress-induced inhibition is inversely colelated 
with the levels of hsp70 present in the lysate (Matts and Hurst, 1992) and that delatured 
proteins trigger the inhibition of protein synthesis in lysates suggest a relationship ~ong 
the activation of HRI, denatured proteins, and hsp70. To determine whether hsp7(i) binds 
to denatured proteins, an anti-BSA antibody was used to determine whether hsp70 cluld be 
co-adsorbed from the lysates with RCM-BSA or BSA. Hsp70 from hemin-suppletented 
lysates was immune-specifically coadsorbed with the RCM-BSA, but not native BSA, by 
the anti-BSA antibody (Fig. 18). Western blot analysis of immunoprecipitated RC~-BSA 
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detected no bound HRI (data not shown), indicating that: (i) RCM-BSA binds to hsp70 
directly; and (ii) RCM-BSA does not bind to HRI and affect its activity. HRI from control 
lysates (no additions) or from the lysates containing BSA or RCM-BSA was adsorbed 
I 
using the anti-HR! mAb F. Western blot analysis indicated that hsp70 was coaforbed 
with HRI from both the control lysate and the lysate containing the native BSA, but not 
from the lysates containing the RCM-BSA (Fig. 18B). 
The data suggest that the mechanism by which denatured proteins trigger the 
inhibition of protein synthesis in hemin-supplemented lysates is through the capJcity of 
denatured proteins to bind and sequester hsp70, blocking the interaction of HJI with 
hsp70, which subsequently activates HRI. 
Heat Shock Blocks the Interaction of Hsp70 with HRI and Activates HRI. 
Heat Shock Inhibits Protein Synthesis in Hemin-supplemented Lysates. Protein 
synthesis in hemin-supplemented lysates was observed to become inhibited in respof se to a 
heat shock (42 °C), confirming previous reports (Bonanou-Tzedaki et al., 1978; Ernst et 
al., 1982) (Fig. 19). The heat shock-induced inhibition of protein synthesis in hemin-
supplemented lysates occurred more slowly and was not as severe as the inf bition 
observed in heme-deficient lysates. An increase in eIF-2a phosphorylation was ol:lserved 
in response to heat shock in hemin-supplemented lysate (Fig. 20, lane 3). TJe heat 
induced e!F-2a phosphorylation was significantly reduced by preincubation of the f ysates 
with the anti-HR! mAb F (Fig. 20, lane 5), indicating that heat shock induces the activation 
of HRI which results in shut-off of protein synthesis. 
Hsp90 and the ECl Antigen Remain Bound to HRI During Heat Shock. Hsp90 
and the ECl antigen associate with inactive HRI in hemin-supplemented lysates and 
dissociate from HRI in conjunction with activation of HRI during heme-deficiencyl~Matts 
et al., 1992). Therefore, it was of interest to determine whether the activation of kRI in 
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heroin-supplemented lysates in response to heat shock occurs in conjunction ith the 
dissociation of hsp90 or the ECl antigen. The hsp90 from the heroin-supplemented lysates 
incubated at 30 °C control) or at 42 °C (heat shocked) was immunoadsorbed by the 803 
I 
anti-hsp90 mAb. Western blot analysis indicated that HRI was quantitatively coadsorbed 
with hsp90 (pellets) from both control and heat shocked lysates (Fig. 21). 1e data 
indicate that no dissociation of hsp90 from HRI is required for the activation of HRI in 
response to heat shock. Similarly. using the 4322 anti-hsp90/hsp70 polyclonal •+body. 
hsp90 was detected to be coadsorbed with HRI by the anti-HR! mAb F from both heat 
shocked and control lysates (Fig. 22). 
HRI was also co-adsorbed with the ECl antigen by the ECl mAb from control and 
heat shocked hemin-supplemented lysates (Pig. 23, pellets). The quantitative rem~val of 
HRI by the ECl mAb (Fig. 23, supernatant) indicated that activation of HRI in hemin-
supplemented lysates in response to heat shock is not accompanied with its dissocJtion of 
the ECl antigen. 
Hsp70 Dissociates from HRI During Heat Shock. Hsp70 was found to associate 
with HRI in both heme-deficient and hemin-supplemented lysates (Matts et al.JI 992). 
HRI was adsorbed from control and heat shocked hemin-supplemented lysates (th the· 
anti-HRI mAb F. Western blot analysis indicated that hsp70 was coadsorbed wifh HRI 
from the control lysate, but not from the heat shocked lysate (Fig. 24). The results ilidicate 
that hsp70 dissociates from HRI during heat shock. This observation was consisteht with 
the observation that hsp70 is released from HRI upon its activation in the presjnce of 
denatured proteins. 
Hsp70 Can Bind Back to HRI when Heat Shock Is Removed. The loss of HRI 
bound hsp70 in response to heat shock could be due to the accumulation of th1 heat-
induced denatured proteins, which bind and sequester hsp70, or due to a heat-Jduced 
change in the conformation of HRI, which makes HRI be unable to associate with hsp70. 
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Therefore, we examined whether hsp70 could reassociate with HRI that had been activated 
by heat stress. HRI was immunoprecipitated from the control or heat shocked lysatJ by the 
anti-HR! rnAb F, and subsequently reincubated with HRI-free control or heat-shocked 
I 
HRl-free lysates (reconstitution reaction supernatants). The reassociation of hsplO with 
HRI was observed when the control pellet was incubated with the control or heat shocked 
reconstitution reaction supernatant at 30 °C (Fig. 25, lanes 1 & 2). No hsp~O was 
observed to bind back to HRI when the heat shocked pellet was incubated with the heat 
shocked reconstitution reaction supernatant (Fig. 25, lane 4). In contrast, when tle heat 
shocked pellet was incubated with the control reconstitution mixture, hsp70 was oJserved 
to bind back to HRI (Fig. 25, lane 3). The data indicate that the loss of HRI bound hsp70 
in hemin-supplemented lysates in response to heat shock is not due a heat-ilduced 
conformational change in HRI, which results in the loss of the hsp70 binding site l• HRI. 
The data support the hypothesis that heat shock induces the denaturation of protjeins in 
lysates, which bind and sequester free hsp70. Subsequently, the interaction of hsplO with 
HRI is blocked, which activates HRI and leads to the inhibition of protein synt esis in 
hemin-supplemented lysates. 
Oxidants Activate HRI Through A Pathway Differed from That of Heat Shock. 
HRI is also activated in hernin-supplemented lysates upon the addition of OXiidants, 
such as N-ethylmaleimide (NEM) or heavy metal ions (Hg++) (Hunt, l 979; Hurs\ et al., 
1987; Matts et al., 1991). Preincubation of hemin-supplemented lysates with the anti-HRI 
rnAb F did not prevent the activation of HRI caused by the addition of Hg++ (Fig. 26) or 
NEM (Fig. 27). In addition, the activation of HRI in heme-deficient lysates wjas not 
blocked by the preincubation of the lysates with the anti-HR! mAb F (Fig. 26). 
The activation of HRI in heme-deficient lysates correlates with the dissoci tion of 
hsp90 and the ECl antigen from HRI with hsp70 remaining bound (Matts et al., 1992), 
while the activation of HRI in response to heat shock correlates with the dissocia ion of 
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hsp70 with hsp90 and the ECl antigen remaining bound. Therefore, we examird the 
interactions of HRI with its associated heat shock proteins during the procesj of its 
activation upon the addition of the oxidants. Western blot analysis indicated that HRI was 
coadsorbed with hsp90 by the 8D3 anti-hsp90 mAb from hemin-supplemented l1ysates 
incubated with 10 mM of NEM or 25 µM of Hg++ (Fig. 28). Similarly, the coadsbrption 
of HRI with the ECl antigen by the ECl mAb from the NEM or Hg++ treated retichiocyte 
lysates was observed (Fig. 29). Furthermore, Western blot analysis indicated thal hsp70 
remained bound to HRI adsorbed from hemin-supplemented lysates after its activltion in 
response to the addition of NEM or Hg++ (Fig. 30). 
Discussion 
HRI interacts with hsp90, hsp70, and the ECl antigen in rabbit reticulocyte lysates. 
Activation of HRI in reticulocyte lysates correlates with alterations of these interLtions. 
I 
By characterizing the composition of HRl/hsps complexes during the activation of IRI and 
the effect of the anti-HRI mAb on HRI activation, three different pathways for activating 
HRI have been distinguished. These three pathways are summarized in Table 2. J 
Pathway I refers the activation of HRI in heme-deficiency. In heme-d ficient 
lysates, activation of HRI correlates with the dissociation of hsp90 and the ECl lntigen 
from HRI, while hsp70 remains bound to HRI. The activation of HRI throulh this 
pathway cannot be prevented by pre-incubation with the anti-HR! mAb. We notr that 
although hsp70 remains bound to HRI in pathway I, changes in the interaction 01 hsp70 
with HRI during heme-deficiency have been observed. A transient decrease was o1served 
in the amount of hsp70 bound to HRI after 5 min of incubation. This transient dltcrease 
was observed when Jysates were treated with apyrase. However, without tyrase 
treatment, this decrease in the amount of HRI-bound hsp70 in heme-deficient lysaies was 
not observed. Interestingly, more hsp70 was observed to bind to HRI at 5 min colpared 
to longer incubation in the presence of ATP in heme-deficient lysates (data not showh). 
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We are currently trying to determine the basis for the apparently contratlictory 
results. Hsp70 binds ADP more tightly than ATP to form a binary complex, which binds 
to lhe unfolded protein more rapidly that free hsp70 (Greene and Eisenberg, 1990; f a11eros 
et al., 1992). Dissociation of hsp70 from its bound proteins requires ATP-hydrolysis, 
which involves an ADP/ATP exchange reaction (Sadis and Hightower, 1992). In heme-
deficient lysates, protein synthesis occurs at a normal rate before the reversing factor is 
sequestered by phosphorylated eIF-2 (elF-2(aP)). During that period, usually Jbout 5 
min, a large amount of nascent polypeptides is produced. With the apyrase treltment, 
hsp70 only binds ADP since no ATP is available. These hsp70/ADP binary co,~'.exes 
may bind to the nascent polypeptides, resulting in a loss of hsp70 from HRI. _[ith a 
longer incubation during heme-deficiency, the nascent polypeptides may fold or assemble 
with the assistance of hsp70. Hsp70 would be released from the polypeptides, uJon the 
exchange of ATP for ADP, and hsp70 would bind back to HRI. If ATP is present during 
immunoprecipitation, free hsp70 would be present in lysates upon the hydrolysis o[ ATP. 
Therefore, the association of HRI with hsp70 could be observed at any time pbint of 
incubation in heme-deficient lysates. 
Pathway II represents the pathway for the activation of HRI in response to the 
addition of denatured proteins or heat shock in hemin-supplemented lysates. n this 
pathway, HRI remains associated with hsp90 and the ECl antigen, but not with hsp70. 
This finding suggests that hsp70 may play a role in keeping HRI in an inactive form in 
hemin-supplemented lysates. The activation of HRI that occurs due to the loss of bound 
hsp70 can be reversed by pre-incubation of the anti-HR! mAb. However, once I RI is 
activated by heat shock, the anti-HR! mAb F has little effect on the HRI activity (dlata not 
shown). Therefore, it appears as if the antibody affects the activation of HRI but hot the 
catalytic activity of activated HR!. This observation suggests that HR! undeioes a 
conformational change during its activation in response to heat shock, which conrelates 
with the release of hsp70 from HRI. This conformation change probably involves amino 
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acids present in the "kinase insertion sequence" in HRI, which contains the antigenic site 
recognized by the mAb F (Chen et al., 1991a,b). This region represents a unique iJsertion 
of approximately 140 amino acids located between the conserved domains V and VI lrresent 
in all known protein kinases (Chen et al., 1991a,b). 
Evidence suggests that the rate~limiting steps for the expression of heat-induced 
damage in mammalian cells involve protein denatration (Lepock, 1987; Lepock et ail. 1988; 
Pinto et al., 1991). The release of hsp70 from HRI during heat shock may be the rlsult of 
the accumulation of denatured proteins in lysates caused by heat shock. wJen the 
concentration of denatured proteins reaches at a certain level, the free hsp70 in thJ lysate 
would be sequestered in complexes with denatured proteins, which blocking the in1action 
of hsp70 with HRI. In the absence of bound hsp70, HRI would be activated, leatling to 
the shutdown of the protein synthesis. 
The proposed mechanism would also ensure that the rate of protein synthesis within 
a cell could not exceed the capacity of the cell to transport, fold, assemble or otHerwise 
process newly synthesized proteins properly. Nacent polypeptides that are destlned to 
enter the lumen of the endoplasmic reticulum (ER) or the mitochondrial matrix are Jhought 
to be maintained in a conformation that is competent of undergoing transport by c1tosolic 
hsp70 (Lindquist and Craig, 1988; Schlesinger, 1990; Welch, 1990). Mitochondrial hsp70 
is reuired for the translocation of polypeptides and their folding in the mitochondrial matrix 
(Linduist and Craig, 1988; Ang et al., 1991; Ellis and van der Vies, 1991). The hsp70 
homolog of the ER (Bip or grp78) is essential for protein transfer into the lumen of the ER. 
Secretory proteins accumulate in the cytosol in yeast in the absence of functiojal Bip 
(Vogel et al., 1990). The inability of proteins to be translocated into the IER or 
mitochondria, or to be properly folded or assembled within these organelles, may ~ead to 
the accumulation of nascent polypeptide precursors within the cytoplasm, These 1ascent 
polypeptides would compete with HRI (or a homologous kinase) for the binding oflhsp70. 
The subsequent activation of the eIF-2a kinase would inhibit protein synthesis. Therefore, 
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nascent polypeptides probably represent a physiologically relevant pool of hsp70 binding 
substrates. A global inhibition of protein synthesis, through the activation of HkI or a 
homologous eIF-2a. kinas, may be important for maintaining the viability of stresJd cells 
that do not constitutively express sufficient levels of hsp70 to protect cells from d ge. 
Pathway III describes the activation of HRI in response to the addition of o idants, 
such as NEM and Hg++, to heroin-supplemented· lysates. Similar to heme-def ciency 
(pathway I), the activation of HRI induced by oxidants cannot be prevented 
incubation with the anti-HR! mAb F and hsp70 remains bound to HRI. On the oth hand, 
HRI remains associated with hsp90 and the ECl antigen, which is similar to the 
mechanism proposed for pathway II. However, hsp70 is observed to remain b und to 
HRI in pathway III, which distinguishes this pathway from that in pathway II. 0 idative 
conditions have been proposed to possibly cause a rearrangement of disulfide bonds within 
HRI, which may lead to the stable binding of hsp70 to HRI. 
Figure 12. Immunological Properties of Hsp70 Associated with HRI in Rabbit 
Reticulocyte Lysates. 
Proteins from 10 µl of hemin-supplemented ( +H) and heme-deficient (-H) 
protein synthesis mixes were adsorbed with non-immune control (C) or the 
anti-HRI (/) antibody bound to GAG-agarose in the presence of TBS as 
described under "Experimental Procedures". The adsorbed prtoteins were 
Western blotted with the C92 anti-hsp72 (Upper) or with the N27 anti-
hsp72/hsc73 (Lower) antibody to detect the presence of hsp70. L, 1.25 µl 
of unincubated whole reticulocyte lysates. 
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Figure 13. Requirement for ATP-Hydrolysis in Releasing of Hsp70 from HRI. 
Proteins from 10 µ1 of apyrase treated (10 µ1 protein synthesis mixes per 
unit apyrase, on ice for 15 min) hemin-supplemented ( +H) and heme-
deficient (-H) protein synthesis mixes were adsorbed with non-immune (C) 
or the anti-HR! (/) antibody in the presence of TBS, as described under 
"Experimental Procedures". The adsorbed proteins were then eluted with 5 
mM Mg++ (-ATP) or with 5 mM Mg++ and 1 mM ATP(+ ATP) at 30 °C 
for 5 min. The eluted portion (Sup) and non-eluted portion (Pe[) were then 
Western blotted with the N27 anti-hsp70 mAb to detect the presence of 
hsp70, respectively. The non-eluted portion were also blotted with the anti-
HRI mAb F to show the presence of HRI. L, 1.25 µ1 of unincubated whole 
reticulocyte lysates; HC, heavy chain of IgG. 
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Figure 14. Interaction of HRI with Hsp70 in Heme-Deficient Lysates. 
Protein synthesis mixes were incubated at 30 °C for O min (lane2), 5 min 
(lane3), 10 min (lane 4), 15 min (lane 5), and 20 min (lanes 1, 6, & 7), 
respectively. After incubation, these mixes were immediately treated with 
apyrase (one unit of apyrase per 10µ1 of protein synthesis mix) on ice for 15 
min. Proteins from 10 µl of the apyrase treated heme-deficient (lanes 1 to 
6) and hemin-supplemented (lane 7) protein synthesis mixes were adsorbed 
with non-immune control (lane 1) or the anti-HRI (lanes 2 to 7) antibody 
bound to GAG-agarose in the presence of TBS, as described under 
"Experimental Procedures''. The adsorbed proteins were separated by 10% 
SDS-PAGE followed by Western blot analysis, probing with the N27 anti-
hsp70 mAb, to detect the interaction of HRI with hsp70. HC, heavy chain 
of IgG. 
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Table I The Amount of Hsp70 Associated with HRI During the Activation 
Process in Heme-Deficient Reticulocyte Lysate. 
Band Antibody Heroin Incubation Quantity 
No. Added Added (30 °C) ODxMM2 
-------------------------------------------------------------------------·-------------
1 Non No Omin 
2 mAbF No Omin 0.257 
3 mAbF No 5min 0 
4 mAbF No lOmin 0.127 
5 mAbF No 15 min 0.143 
6 mAbF No 20min 0.135 
7 mAbF Yes 20min 0.125 
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Figure 15. Inhibition of Protein Synthesis and the Amount of Hsp70 Associated with HRI 
in Heme-Deficient Lysates. 
Protein synthesis was measured by the incorporation of 14C-leucine into 
acid precipitable protein at 30 °C in the hemin-supplemented ( +H) and 
heme-deficient (-H) protein synthesis mixes, as described under 
"Experimental Procedures". The amount of hsp70 associated with HRI was 
determined by a densitometer and the result was shown in Figure 14 and 
Table l. 
72 
40000 N e e 







0 10 20 
Time (min) 
Figure 16. Effect of Denatured Proteins on Protein Synthesis in Heroin-Supplemented 
Reticulocyte Lysates. 
(A) Protein synthesis was measured at 30 °C in standard (40 µl) rabbit 
reticulocyte lysate reaction mixtures containing 20 µM hemin with no 
additions(<>-<>) or with the addition of 20 µM BSA(•-•), RCM-BSA (D-
D), LA (e-e), RCM-LA (o-o), LG (.&-.&), or RCAM-LG (.t.-.t.). The 
amount of [14C]leucine incorporated into acid precipitable protein in a 5 µl 
aliquot was determined at the times indicated in the figure. (B) Hemin-
supplemented protein synthesis mixtures were incubated for 30 min at 30 °C 
with no additions (controls), or with varying concentrations of RCM-BSA 
(D-D), RCM-LA (0-0), or RCAM-LG (.t.-.t.). The amount of protein 
synthesis is reported as the amount of [14C]leucine incorporated into acid-
precipitable protein in 30 min relative to the amount incorporated in the 
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Figure 17. Addition of the Anti-HRI mAb F Blocks the Phosphorylation of eIF-2cx. 
Induced by RCM-BSA. 
Hemin-supplemented protein synthesis mixes were pre-incubated on ice for 
15 min in the presence of no additions (NONE, lanes 1-3) or in the presence 
of -1 µg IgG/10 µl protein synthesis mix of control monoclonal IgG (MOPC 
21 mouse IgG ascites, Sigma) (lanes 4-6) or anti-HRI mAb F (lanes 7-9). 
Samples were subsequently incubated at 30 °C for 12 min in the presence of 
no additions (lanes 1,4 & 7), or in the presence of 25 µM BSA (lanes 2, 5 
&8) or RCM-BSA (lanes 3, 6 & 9), and then pulsed with [y-32P]ATP for 4 
min. Samples (2.5 µl) were analyzed by SDS/P AGE, as described under 
"Experimental Procedures", followed by autoradiography. 
76 
NONE I CONTROL IANTI-HRI 
-elF-2cx 
12 3 456 789 
Figure 18. Analysis of the Capacity of RCM-BSA to Bind Hsp70 and Block the 
Interaction of Hsp70 with HRI in Hemin-Supplemented Lysates. 
(A) Western blot analysis comparing the capacity of hsp 70 to bind to 
RCM-BSA versus BSA. (B) Western blot analysis comparing the capacity 
of RCM-BSA versus BSA to block the interaction of hsp 70 with HRI. 
Hemin-supplemented protein synthesis mixes (20 µl for A, or 10 µl for B) 
were incubated at 30 °C for 30 min in the presence of no additions (lanes 1 
& 2), or in the presence of 25 µM BSA (lanes 3 & 4) or RCM-BSA (lanes 5 
& 6). Proteins adsorbed by rabbit anti-BSA (A, lanes 2, 4 & 6), anti-HRI 
mAb F (B, lanes 2, 4 & 6), or non-immune control antibodies (A & B, 
lanes 1, 3, & 5) were resolved by SDS/PAGE and hsp 70 was detected by 
Western blotting as described under "Experimental Procedures". HC, 









Figure 19. Effect of Heat Shock on Protein Synthesis in Hemin-Supplemented Lysates. 
Protein synthesis was measured in standard reaction mixtures at 30 °C in the 
absence (-h) or presence (+h) of 20 µM hemin-HCl, or at 42 °C in the 
presence of hemin (42 °C). The amount of 14C-leucine incorporated into 
acid precipitable protein in a 5 µl aliquot was determined at the times 
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Figure 20. Heat Shock Induces the Activation of HRI in Hemin-Supplemented Lysates. 
Hemin-supplemented (lanes 1 & 3-5) and heme-deficent (lane 2) protein 
synthesis mixes were pre-incubated on ice for 15 min in the presence of no 
additions (lanes 1 to 3) or in the presence of - 1 µg lgG per 10 µl of protein 
synthesis mix of control monoclonal IgG (MOPC 21 mouse lgG ascites, 
Sigma) (lane 4) or anti-HR! mAb F (lane 5). Samples were subsequently 
incubated at 30 °C (lanes I & 2) or at 42 °C (lanes 3 to 5) for 20 min, and 
then pulsed with [y-32P]A TP for 4 min. Samples (2.5 µl) were analyzed by 
8% SDS-PAGE followed by autoradiography. 
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Figure 21. Coadsorption of HRI with Hsp90 by the 8D3 Anti-hsp90 mAb in Heat 
Shocked Hemin-supplemented Lysates. 
Hemin-supplemented protein synthesis mixes were incubated at 30 °C or 42 
°C for 20 min. Proteins from 2.5 µl of the incubated protein synthesis 
mixes were adsorbed with the non-immune control (C) or the 8D3 anti-
hsp90 (/) antibody bound to GAM-agarose in the presence of TB, as 
described under "Experimental Procedures". The adsorbed (Pel) and non-
adsorbed (Sup) fractions were immunoblotted with the anti-HR! mAb F for 
the presence of HRI. 
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Figure 22. Coadsorption of Hsp90 with HRI by the Anti-HRI mAb Fin Heat Shocked 
Heroin-Supplemented Lysates. 
Heroin-supplemented protein synthesis mixes were incubated at 30 °C or 42 
°C for 20 min. Proteins from 10 µl of the incubated protein synthesis mixes 
were adsorbed with the non-immune control (C) or the anti-HRI (/) 
antibody bound to GAG-agarose.in the presence of TBS, as described 
under "Experimental Procedures". The adsorbed fractions were Western 
blotted with the 4322 anti-hsp90/hsp70 antibody to detect the presence of 
hsp90. HC, heavy chain of IgG. 
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Figure 23. Interaction of HRI with the ECl Antigen in Heat Shocked Hemin-
Supplemented Lysates. 
Hemin-supplemented protein synthesis mixes were incubated at 30 °C or 42 
°C for 20 min. Proteins from 2.5 µl of the incubated protein synthesis 
mixes were adsorbed with the non-immune control (C) or the ECl ([) 
antibody bound to GAG-agarose in the presence of TB as described under 
"Experimental Procedures". The nonadsorbed (Sup) and adsorbed (Pel) 












Figure 24. Heat Shock Blocks the Interaction of HRI with Hsp70. 
Hemin-supplemented protein synthesis mixes were incubated at 30 °C or 42 
°C for 20 min followed by apyrase treatment (one unit of apyrase per 10 µl 
of protein synthesis mixes) on ice for 15 min. Proteins from 10 µl of the 
apyrase treated protein synthesis mixes were adsorbed with the non-immune 
control (C) or the anti-HRI (/) mAb Fin the presence of TBS as described 
under "Experimental Procedures". The adsorbed fractions were Western 
blotted with the 4322 anti-hsp90/hsp70 antibody to detect the presence of 





Figure 25. Reassociation of HRI with Hsp70 After Heat Shock Is Removed. 
Hemin-supplemented protein synthesis mixes were incubated at 30 °C or 42 
°C for 20 min followed by apyrase treatment (one unit of apyrase per 10 µl 
of protein synthesis mixes) on ice for 15 min. Proteins from 10 µl of 
protein synthesis mixes were adsorbed with the non-immune control (C) or 
the anti-HRI (/) antibody bound to GAG-agarose in the presence of TBS 
under "Experimental Procedures". After washing five times with TBS, the 
pellets were then reincubated with the HRI-free hemin-supplemented protein 
synthesis supernatants (which had been preincubated at 30 °C or 42 ·c for 
20 min) at 30 °C for 5 min. After incubation, the pellets were washed with 
TBS containing 0.1 % SDS, 1 % DOC, and 1 % Triton 100 to remove the 
non-specific binding. The adsorbed fractions were separated by SDS-
PAGE followed Western blotting with the 4322 anti-hsp90/hsp70 antibody 
to detect the presence of hsp70. Lane 1, 30 °C pellet incubated with 30 °C 
supernatant; lane 2, 30 °C pellet incubated with 42 °C supernatants; lane 3, 
42 ·c pellet incubated with 30 ·c supernatant; and lane 4, 42 ·c pellet 
incubated with 42 °C supernatant. HC, heavy chain of IgG. 
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Figure 26. The Ability of Anti.-HRI mAb F to Prevent the Activation of HRI. 
Hemin-supplemented (+H, 42 °C, and Hg++) and heme-deficient (-H) 
protein synthesis mixes w~re pre-incubated on ice for 15 min in the 
presence of no addition (-) or in the presence of - 1 µg IgG per 10 µl of 
protein synthesis mix of control monoclonal IgG (MOPC 21 mouse IgG 
ascites, Sigma) (CJ or anti.-HRI mAb F (/). Samples were subsequently 
incubated at 30 °C (+H, -H, and Hg++) or 42 °C for 20 min, and then pulsed 
with [y-32P]ATP for 4 min. Samples (2.5 µl) were analyzed by 8% SDS-
PAGE followed by autoradiography. 
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Figure 27. The Anti-HR! mAb Cannot Prevent the Activation of HRI Induced by NEM. 
Hemin-supplemented (lanes 1 ~ 3-5) and heme-deficient (lane 2) protein 
synthesis mixes were pre-incubated on ice for 15 min in the presence of no 
additions (lanes 1-3) or in the presence of,.., 1 µg IgG per 10 µl of protein 
synthesis mix of control monoclonal IgG (MOPC 21 mouse IgG ascites, 
Sigma) (lane 4) or anti-HR! mAb F (lane 5). Samples were subsequntly 
incubated at 30 °C in the presence of no additions (lanes 1 & 2) or in the 
presence of 10 mM of NEM (lanes 3-5) for 15 min, and then pulsed with 
[y-32P]ATP for 4 min. Samples (2.5 µl) were analyzed by 8% SDS-PAGE 
followed by autoradiography. · 
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Figure 28. Interaction of HRI with Hsp90 in Hemin-Supplemented Lysates Treated with 
NEM or Hg++. 
Proteins from 2.5 µl of hemin-supplemented protein synthesis mixes (a) 
with no addition, (b) with 25 µM Hg++, (c) with 5 mM NEM, or (d) at 37 
~C for six hours, were adsorbed with non-immune control (C) or the 8D3 
(/) antibody bound to GAM-agarose. The non-adsorbed (Sup) and 
adsorbed (Pel) fractions were immunoblotted with the anti-HRI mAb to 
detect the presence of HRI. HC, heavy chain of IgG. 
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Figure 29. Interaction of HRI with the ECl Antigen in Hemin-Supplemented Lysates 
Treated with NEM or Hg++. 
Proteins from 2.5 µl of hemin-supplemented protein synthesis mixes (a) 
with no addition, (b) with 5 mM NEM, (c) with 25 µM Hg++, or (d) at 42 
~C for 30 min, were adsorbed with non-immune control (C) or the ECl (I) 
antibody bound to GAG-agarose. The non-adsorbed (Sup) and adsorbed 
(Pel) fractions were immunoblotted with the anti-HRI mAb to detect the 
presence of HRI. 
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Figure 30. Interaction of HRI with Hsp70 in Hemin-Supplemented Lysates Treated with 
NEM or Hg++. 
Proteins from 10 µl of hemin-supplemented protein synthesis mixes with no 
addition (lane 1) or with 5 mM NEM (lane 2) or with 25 mM Hg++ (lane 3), 
were adsorbed with non-immune control (C) or the anti-HRI (1) antibody 
bound to GAG-agarose. The adsorbed fractions were imrnunoblotted with 
the N27 anti-hsp70 mAb to detect the presence of hsp70. L, 1.25 µl of 
unincubated whole reticulocyte lysate; HC, heavy chain of IgG. 
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Table II Three Pathways for Activation of HRI in Rabbit Reticulocyte Lysates 
Activating Sensitivity Composition of HRI-hsps Complex 
Pathway to the -------------------------------------------
Conditions anti-HRI mAb hsp90 hsp70 hsp56 
I Heme-Deficiency Resistance no yes no 
II Heat Stress Sensitive yes no yes 




RECONSTITUTION OF HRI-HSPS COMPLEX 
Introduction 
The heme-regulated inhibitor (HRI) in rabbit reticulocytes and their lysates is a 
cAMP-independent protein kinase participating in the control of protein synthesis at the 
initiation level (Howard et al., 1970; Maxwell et al., 1971; Hunt et al., 1972; Hunt, 1979; 
Ochoa, 1983; London et al., 1987; Jackson, 1991). Activated HRI specifically 
phosphorylates the 38 kDa a-subunit of the eukaryotic initiation factor 2 (eIF-2cx.) (Levin et 
al., 1976; Ranu and London, 1976; Kramer et al., 1976; Farrell et al., 1977). The 
phosphorylated eIF-2(cx.P) binds and sequesters the reversing factor RF, also termed eIF-
2B or GEF, guanine nucleotide exchange factor, which is required for eIF-2 recycling 
(Matts et al., 1983; Pain and Clemens, 1983; Panniers and Henshaw, 1983; Siekierka et 
al., 1984). The unavailability of RF results in the cessation of the initiation of protein 
synthesis in reticulocyte lysates (Matts et al., 1983; Matts and London, 1984; Thomas et 
al., 1984; Matts et al., 1986). Although the mechanism for the control of translation by 
HRI has been extensively studied, little is known about the regulation of HRI itself. 
Heat shock proteins (hsp) are a small number of highly conserved proteins whose 
synthesis is dr.amatically induced at high temperatures (Lindquist and Craig; 1988; 
i 
Schlesinger, 1990). Some major heat shock proteins, such as hsp90, hsp70 andihsp60, 
are members of multi-gene families which include proteins expressed in cells at normal 
temperature (Lindquist, 1986; Lanks, 1986, Bond and Schlesinger, 1988; Schlesinger, 
1990; Morimoto et al., 1992). Hsp90 is an abundantly expressed, vital protein that is 
found complexed with various biologically important proteins, such as the steroid hormone 
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receptors and pp6ov-src (Courtneidge and Bishop, 1982; Brugge et al., 1983; Pratt, 1990; 
Smith et al., 1990; Abravay et al., 1992; Edwards et al., 1992). The ECl antige~, which 
' 
I 
has been identified as a 56 kDa heat shock protein (S~chez, 1990), is often associated 
with hsp90-substrate complexes (Smith et al., 1990) and binds the immunosuppressant 
FK506 (Lebeau et al., 1992; Yem et al., 1992; Tai et al., 1992). Hsp70 participates in 
i 
protein folding, the translocation of proteins across membranes, the asse~bly of 
monomeric proteins to larger macromolecular complexes, and the disassembly of protein 
aggregates (reviewed by Pelham, 1990; Gething and Sambrook, 1992). Hsp70 also 
interacts with a number of cellular proteins, such as steroid hormone receptors, heat shock 
factors, and the mutant form of p53 (Kost et al., 1989; Sanchez et al., 1990b; Smith et al., 
1990a; Edwards et al., 1992; Smith et al., 1992; Scherrer et al., 1992; Abravaya et al., 
1992; Hainaut and Milner, 1992). Recently, hsc70 (the constitutively expressed form of 
hsp70) has been reported to interact with the immunosuppressant deoxyspergualin (Nadler 
et al., 1992). However, the functional significance of these associations between heat 
shock proteins and cellular proteins remains to be established. 
Previous work has demonstrated that HRI associates with hsp90, hsp70, and 
hsp56 (the ECl antigen) in rabbit reticulocyte lysates (Matts and Hurst, 1989; Matts et al., 
1992). The interactions of HRI with hsp90 and the ECl antigen are stabilized by h~min in 
lysates (Matts et al., 1992). Hemin has been reported to bind to HRI, suppressing its 
activation (London et al., 1985). Activation of HRI in heme-deficiency, which is a 
multistage process (Hunt, 1979; Jackson, 1991), has been observed to occur in 
conjunction with the dissociation of hsp90 and the ECl antigen, while hsp70 rrmains 
bound to HRI (Matts et al., 1992). In contrast, the activation of HRI in hemin-, 
l 
i 
supplemented lysates in response to heat shock and other forms of stress I is not 
accompanied by the dissociation of hsp90 and the ECI antigen. However, the dissociation 
of hsp70 from HRI has been observed during the activation of HRI in response to heat 
shock in hemin-supplemented lysates (Chapter III). Furthermore, the ability of hemin to 
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restore protein synthesis in heme-deficient lysates correlated with the levels of hsp90 
i 
present, while the ability of lysate to resist stress-induced inhibition of protein s~nthesis 
correlated with the levels of hsp70 present (Matts and Hurst, 1992). These observations 
support the notion that hsp90, hsp70, and the ECl antigen play a fundamental role in 
regulating the activation and the activity of HRI, although the molecular mechanism for this 
I 
regulation is unclear. 
In order to determine the significance of the associations of hsps with HRI and to 
better understand the mechanism for the assembly of the HRI-hsps multiprotein complex in 
vivo, we have examined the requirements for reconstituting the HRI-hsps complex in the 
rabbit reticulocyte lysate system. This system has been successfully applied to the 
reconstitution of complexes of hsps with glucocorticoid receptor, progesterone receptor, 
and pp6osrc, respectively (Scherrer et al., 1990, 1992; Smith et al., 1992; Hutchiso,n et al., 
1992). The data presented here indicate that: (i) the binding of hsp90 to HRI requires the 
presence of heroin and elevated incubation temperature (30 °C); (ii) the ECl antigen is not 
required for the binding of hsp90 to HRI; (iii) the ECl antigen can bind to HRl in the 
absence of hsp90 and the binding is also heroin dependent; (iv) ATP and Mg++ facilitate the 
binding hsp70 to HRI; (v) the binding of hsp90 to HRI-hsp70 complexes does not require 
ATP-hydrolysis, and Mg++ facilitates this reaction; and (vi) if hsp70 is not associatd with 




Goat anti-mouse IgM and IgG were obtained from Jackson Immunor~search 
! 
Laboratories. Apyrase (grade VIII), N-ethylmaleimide (NEM), nitro blue tetrazolium, 5-
bromo-4-chloro-3-indolyl phosphate, p-nitrophenyl-agarose, mouse IgM (TEPC 183), and 
mouse IgG (MOPC 21) were obtained from Sigma. Alkaline phosphatase conjugated to 
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rabbit anti-mouse IgG or to goat anti-rabbit IgG was obtained from ICN. The 8D3 anti-
hsp90 IgM monoclonal antibody (mAb) (Perdew, 1988; Perdew and Whitelaw, 19rl) was 
provided by Dr. Gary Perdew (Purdue University); the KN382/EC1 IgG mAb (ECl) (Tai 
et al., 1986) was provided by Dr. Lee Faber (Medical College of Ohio, OH); the N27F3-4 
(N27) anti-hsp70 IgG mAb (Kost et al., 1989; Welch and Suhan, 1986) was purchased 
! 
from StresGen; the anti-HRI IgG mAb F (Pal et al., 1991) was provided by Dr. J.J. Chen 
(Massachusetts Institute of Technology). The 4322 rabbit anti-hsp90/hsp70 antiserum 
(Erhart et al., 1988) was provided by Dr. Stephen Ullrich (National Cancer Institute). 
Buffers 
TB, 10 mM Tris-HCI (pH7 .5); TB/50, 10 mM Tris-HCI (pH 7 .5) containing 50 
mM NaCl; TBS, 10 mM Tris-HCI (pH 7.5) containing 150 mM NaCl; TB/500, 10 mM 
Tris-HCI (pH 7.5) containing 500 mM NaCl; TBS/5% NFDM, TBS containing 5% (w/v) 
non-fat dry milk; 4X Sample Buffer, 250 mM Tris-HCI (pH 6.8) containing 16% (v/v) 
glycerol, 5% (w/v) SDS, 0.01 % (w/v) bromophenyl blue (BPB), and 0.055% (w/v) 
dithiothreitol (DTT) (fresh DTT is added just before use). 
Rabbit Reticulocyte lysates and Protein Synthesis Mixtures. 
Reticulocyte lysates were prepared from anemic rabbits as described previously 
(Hunt et al., 1972), using buffered saline containing 5 mM glucose to wash the 
reticulocytes prior to their lysis (Matts et al., 1991). Protein synthesis mixtures with or 
without 20 µM hemin were constructed under the standard conditions, including an ATP 
regenerating system, as described previously (Hunt et al., 1972; Ernst et al., 1978). 
Immunoprecipitation 
p-Nitrophenyl-agarose was rinsed free of isopropanol, and was coupled to goat 
anti-mouse IgG (GAG), or goat anti-mouse lgM (GAM) as described previously (Matts et 
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al., 1992). The preparations contained approximately 1.6 mg of antibody coup1e4 per ml 
of packed agarose. GAG-agarose and GAM-agarose were used as a 1:1 slurry +n TBS. 
The following general procedure describes the quantities of antibodies that were determined 
to quantitatively adsorb hsp90, the ECl antigen, or HRI from 10 µl of reticulocyte lysate 
protein synthesis mix: for the adsorption of hsp90, 8D3 anti-hsp90 mAb from 62.5 µl of 
ascites fluid was bound to 87 .5 µl of GAM-agarose; for the adsorption of the ECl antigen, 
62.5 µl of ECl mAb (2.8 mg/ml) was bound to 100 µl of GAG-agarose; for the adsorption 
of HRI, anti-HR! mAb F from 15 µl of anti-HR! mAb F ascites fluid was bound to 25 µl 
of GAG-agarose. Non-immune control incubations contained equivalent volumes of TEPC 
183 mouse IgM or MOPC 21 mouse IgG ascites with a concentration of approximately 5 
mg of antibody per ml. 
Antibodies were bound to the GAG- or GAM-agarose for two hours on ice. The 
antibody-bound GAG- or GAM-agarose was then washed sequentially with 500 µleach of: 
TBS; TB/500; TBS; and adsorption buffer (either TBS or TB as indicated in the legends of 
the figures). The GAG- or GAM-agarose was pelleted by a 10 sec centrifugation (full 
speed burst) in a Brinkman model 5415 Microfuge. The heme-deficient protein synthesis 
mixes were incubated at 30 °C for 10 min. These mixes were then treated with or without 
apyrase (one unit of apyrase per 10 µl of protein synthesis mix) on ice for 15 min .. After 
the removal of excess adsorption buffer from the GAG- or GAM-agarose pellets containing 
the bound antibodies, 10 µl of protein synthesis mixes were added directly for the 
adsorption of hsp90, the ECl antigen, or HRI. Samples were incubated at 4 °C for two 
hours with continuous mixing. The samples were then diluted 10-fold with 90 µl of 
I 
' 
adsorption buffer, and the non-adsorbed proteins (supernatants) were separated from the 
proteins adsorbed to the agarose (pellets) by centrifugation. 
The pellets were then washed five times with 500 µl of the buffers described below 
to remove nonadsorbed proteins. For the adsorption of hsp90 or the ECl antigen, and 
their associated proteins with the 8D3 anti-hsp90 or the ECl mAbs, the pellets were 
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washed sequentially: once with TB, twice with TB/50, and twice with TB. For the 
adsorption of HRI and its associated proteins with the anti-HR! mAb F, the pellets were 
washed five times with TBS. For the analysis of hsp70 associated with HRI, the pellets 
were washed sequentially: once with TBS, three times with TBS containing 1 % sodium 
deoxycholate, 1 % Triton X-100, and 0.1 % SDS, and once with TBS. 
Reconstitution Reactions 
Hsp90-free lysates were prepared by preincubating heme-deficient lysates with the 
8D3 anti-hsp90 mAb adsorbed to the GAM-agarose pellets at 4 °C for 90 min followed by 
brief centrifugation to pellet the resin as described above. The supernatants were the 
hsp90-free lysates. Similarly, the ECl-antigen-free lysates and the HRI-free lysates were 
prepared by using the ECl mAb and the anti-HR! mAb F preadsorbed to GAG-agarose, 
respectively. These hsp90-free, ECl antigen-free, or HRI-free lysates were referred to 
reconstitution supernatants. For reconstitution, the immune pellets, isolated as described 
above, were incubated with specific reconstitution supernatants (detailed in the legends of 
the figures) at 30 °C for 10 min. The immune pellets were then washed, as described 
above, to remove nonspecifically bound proteins. 
Gel Electrophoresis and Western Blot Analysis 
The immune pellets were extracted with 80 µl of SDS sample buffer and the 
proteins in the samples were resolved on 10% or 8% SDS-polyacrylamide gels (9x14x0.15 
cm; 37.5:1 acrylamide:Bis) using the procedure of Laemmli (Laemmli, 1970). ~roteins 
were transferred to a PVDF membrane (Biorad) at a current density of 2.5 mA/cm2 for 40 
min for Western blot analysis as described previously (Matts and Hurst, 1989; Matts et al., 
1992). Blots were blocked with TBS/5% NFDM for one hour at room temperature. The 
primary antibody was then reacted with the blots overnight at 4 °C. Blots were washed 
twice with TBS containing 0.5% Tween-20, once with TBS, and then blocked with 
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TBS/5% NFDM prior to reaction with alkaline phosphatase-conjugated rabbit anti-mouse 
IgG or goat anti-rabbit IgG (diluted 1: 1000 in TBS/1 % NFDM) for two hours at room 
temperature. Blots were washed twice with TBS containing 0.5% Tween-20, and twice 
with TBS. Proteins were then detected by incubating blots in alkaline phosphatase reaction 
buffer (100 mM Tris-HCl, pH9.5, containing 100 mM NaCl, 100 mM Mg(0Ac)2, 300 
µg/ml NTB and 150 µg/ml BCIP) at 35 °C for 1 to 5 min. 
For detecting HRI, the ascites fluid containing the anti-HR! mAb F was diluted 
1:250 in TBS/1 % NFDM. For detecting hsp90, the 4322 anti-hsp90/hsp70 antiserum was 
diluted 1 :50 in TBS/I% NFDM. For detecting hsp70, the N27 anti-hsc73/hsp 72 mAb was 
diluted 1:1000 in TBS/1 % NFDM. For detecting the ECl antigen, the ECl mAb was 
diluted 1:1000 in TBS/1 % NFDM. 
Results and Discussion 
Hemin and Elevated Temperature Facilitate the Reconstitution of HRI with Hsp90. 
Hsp90 in rabbit reticulocyte lysate was immunoprecipitated from the heme-deficient 
lysates by the 8D3 anti-hsp90 mAb. Hsp90-free lysate was then added to these HRl-free 
8D3 anti-hsp90 pellets. No HRI was coadsorbed with the 8D3 anti-hsp90 mAb under this 
condition (Fig. 31, none). In the presence of 20 µM hemin, HRI from the hspbO-free 
lysate bound back to the hsp90 pellet (Fig. 31, +H, Pel.). No HRI was observed 
remaining in the supernatant after the reconstitution reaction (Fig. 31, +H, Sup.). 
However, much less HRI was observed to bind back to hsp90 in the heme-deficient hsp90-
free lysate (Fig. 31, -H), suggesting that the reassembly of HRI with hsp90 was faqilitated 
by hemin. 
Compared to the non reconstituted condition (Fig. 31, none), in which no HRI was 
coadsorbed with hsp90 from the heme-deficient lysates by the 8D3 anti-hsp90 mAb, a 
significant amount of HRI reassociated with hsp90 under the reconstitution conditions in 
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the absence of hemin (Fig. 31, -H). This observation suggests that the affinity of the 
immunoprecipitated hsp90 for HRI was altered. This alteration may have been caused by 
the loss of some hsp90-associated proteins or factors during the washing of the 8D3 
immune pellets. The lost proteins may play a role in mediating the binding of hsp90 to 
HRI or to other proteins. 
Elevated temperature (30 °C) was required for the reconstitution of functional 
glucocorticoid receptor-hsp90 and progesterone receptor-hsps complexes in rabbit 
reticulocyte lysates (Scherrer et al., 1990; Smith et al., 1990, 1992). HRI-free 8D3 pellets 
were incubated with the hsp90-free lysates in the presence of hemin at O °C or 30 °C. HRI 
was observed to rebind quantitatively to hsp90 after incubation at 30 °C for 5 min (Fig. 
32). However, if the reconstitution reaction was carried out at 4 °C, only about 50% of the 
HRI was observed to rebind to hsp90 after a two hour incubation (Fig. 32). This 
observation suggests that the assembly of hsp90-HRI complex was a temperature and time 
dependent process. 
The ECl Anti&en Is Not Reguired for the Assembly of the HRI-Hsp90 Complex. 
We have previously reported that the interactions of HRI with hsp90 and the ECl 
antigen are dep~ndent upon the presence of hemin in reticulocyte lysates (Matts et al., 
1992). The association ofhsp90 with the ECl antigen has been observed in cytosol 
prepared from human cells, rabbit uteri, calf uteri, chicken oviducts and rabbit reticulocytes 
(Renoir et al., 1990; Matts et al., 1992). Both free hsp90 and free ECl antigen exist in 
reticulocyte lysates (Matts et al., 1992). To determine whether the interaction of hsp90 
' 
with HRI is dependent upon the presence of the ECl antigen in reticulocyte lydtes, we 
I 
examined whether the hemin-dependent association of hsp90 with HRI could be 
reconstituted in ECl antigen-free reconstitution supematants. Western blot analysis of 8D3 
anti-hsp90 pellets indicated that HRI quantitatively reassociated with hsp90 in the presence 
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of hemin, even though no ECl antigen was presented (Fig. 33, +H). No HRI was 
observed to associate with hsp90 in the absence of hemin (Fig. 33, -H). 
Although hsp90 is frequently observed to associate with the ECl antigen, the data 
suggest that the ECl antigen is not required for the heroin-dependent interaction of hsp90 
with HRI in reticulocyte lysates. The ECl antigen has been demonstrated to bind the 
immunosuppressant FK506 (Yem et al., 1992; Tai et al., 1992), suggesting that the ECl 
antigen may have the peptidylproline cis-trans isomerase (PPI) activity. Therefore, the 
ECl antigen may play a role in regulating the activity of proteins with which it is associated 
through its PPI activity. While hsp90 was observed to bind to HRI in absence of the ECl 
antigen in lysates, the ECl antigen could still play a role in regulating the effect that the 
binding of hsp90 has on HRI activity. 
H&P90 Is Not Required for the Binding of the ECl Antigen to HRI. 
To test whether the ECl antigen interacts with HRI via its interaction with hsp90, 
we examined whether the HRI-ECl antigen complex reassembled in reticulocyte lysates in 
the absence of hsp90. In the presence of hsp90, the ECl antigen was observed to 
reassociate with HRI in heroin-supplemented lysate, but not in heme-deficient lysate (Fig. 
34C, with hsp90). This was consistent with previous observations (Matts et al., 1992). 
Surprisingly, we found that the ECl antigen could interact with HRI in the absence of 
hsp90 in lysates, and that this interaction was also heroin-dependent (Fig. 34C, without 
hsp90). This observation is the first evidence which shows that the ECl antigen can 
associate with its binding substrate, bypassing its interaction with hsp90. Compared to the 
lysate containing hsp90, only about 50% of the HRI was observed to reassociate with the 
ECl antigen in the hsp90-free lysate in the presence of hemin. This suggests that hsp90 
may facilitate the interaction between HRI and the ECl antigen. However, another 
explanation for this finding may be that less ECl antigen is available in such lysate, since 
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hsp90 associates with the ECl antigen (Matts et al., 1992). The depletion of hsp90 might 
result in decreasing the amount of the ECl antigen present in the lysates. 
The data show that the interaction of the ECl antigen with HRI does not require the 
presence of hsp90. It creates an opportunity for us to study the biochemical function of the 
ECl antigen in regulating the activities of its substrates. Its potential peptidylproline cis-
trans isomerase activity suggests that the ECl antigen may play a role in altering the 
conformation of its substrates, which may result in changing the activities of the proteins 
with which it interacts. 
The Requirement of ATP and Mg2+ for the Binding of Hsp90 to HRI. 
HRI associates with hsp90 and hsp70 in heroin-supplemented lysates (Matts and 
Hurst, 1989; Matts et al., 1992). Previous experiments indicated that the non-specific 
binding of hsp70 could not be eliminated unless the washing buffer contained detergents 
(0.1 % SDS, 1 % DOC, and 1 % Triton 100) (data not shown). We subsequently found that 
incubation of anti-HRI immune pellets for 5 min at 30 °C in the presence of high salt and 
ATP completely stripped hsp90 and hsp70 from HRI (Fig. 35, lane 3). 
To determine the requirement for ATP and Mg++ for the binding of hsp90 to HRI, 
the salt-stripped HRI-resin was incubated with HRl-free hemin-supplemented lysates at 
different conditions. In the presence of both ATP and Mg++, hsp90 was observed to bind 
back to HRI (Fig. 36, lane 5). Hsp90 did not bind to HRI in the absence of Mg++, 
although ATP was present in the reconstitution reaction mixture (Fig. 36, lane 6). No 
hsp90 was observed to reassociate with HRI in the apyrase treated reconstitution reaction 
mixtures (Fig. 36, lanes 7 and 8). Although non-specific binding of hsp70 was observed 
in this experiment (Fig. 36, lane 4), the binding of hsp70 to HRI was reduced under 
conditions that either lacked Mg++ (lane 6) or ATP (lane7) or both (lane 8), compared to 
conditions where both ATP and Mg++ were presented. 
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The data described above indicated that both ATP and Mg++ are required for the 
! 
binding of hsp90 to HRI, if hsp70 has also been stripped from HRI. Subsequently, the 
ATP requirement for the binding of hsp90 to HRI was examined under conditions where 
hsp70 remains bound to HRI. The 8D3 anti-hsp90 mAb was used to immunoadsorb 
hsp90 and its associated proteins from heme-deficient lysates. The 8D3 anti-hsp90 
immunoprecipitate was incubated with heroin-supplemented hsp90-free lysates Western 
blot analysis indicated that no HRI was reassociated with hsp90 in the absence of heme 
(Fig. 37, lane 1). In contrast, HRI quantitatively rebound to hsp90 in the presence of 
hemin (Fig. 37, lane 2). When the reconstitution reaction mixture was treated with 
apyrase, the association of HRI with hsp90 was still observed (Fig. 37, lane 3). However, 
the binding of HRI to hsp90 was significantly decreased upon the addition of EDTA (5 
mM) to the reconstitution reaction mixture (Fig. 37, lane 4). This effect could be reversed 
by the addition of excess Mg++ (10 mM) (Fig. 37, lane 5). We have not examined the 
efficacy of Mn++ or other divalent actions in reversing the EDT A blockage of protein 
binding. 
From these data, it appears that the requirement of ATP and Mg++ for the binding 
of hsp90 to HRI is affected by whether hsp70 is bound to HRI. If hsp70 is not associated 
with HRI, the binding of hsp90 to HRI requires both ATP and Mg++. If hsp70 is bound 
to HRI, the binding of hsp90 to HRI requires only Mg++, but not ATP. The data suggest 
that Mg·ATP is required for the binding of hsp70 to HRI, while Mg++ is needed for the 
binding of hsp90 to the HRI-hsp70 complex. Once hsp70 is associated with HRI, the 
binding of hsp90 to HRI is not ATP dependent. 
i 
The interactions of HRI with hsp90, hsp70, and the ECl antigen are summaiized in 
a model described in Figure 38. This model is based on several observations: (i) the 
interaction of HRI with hsp90 and the ECl antigen is hemin dependent (Matts et al., 1992); 
(ii) the interaction of HRI with hsp70 is not dependent on hemin (Matts et al., 1992); (iii) 
hsp90, hsp70, and the ECl antigen form a hsps complex in the lysates (Matts et al., 1992); 
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(iv) the ECl antigen is not required for binding of hsp90 to HRI; (v) although hsp90 
interacts with the ECl antigen (Matts et al., 1992), the binding of the ECl antigen to HRI 
is not dependent upon the presence of hsp90; (vi) the binding of hsp70 to HRI requires 
ATP, and Mg++ facilitates this interaction; and (vii) the binding of hsp90 to HRI requires 
Mg++, but not ATP. 
Figure 31. Effect of Hemin on Reconstitution of HRI-Hsp90 Complex 
The non-immune control (C) or the 8D3 (/) resin was incubated with the 
hsp90-free reconstitution reaction supematants in the presence of hemin 
(+H) or in the absence of hemin (-H) at 30 °C for 5 min. The reassociated 
(Pel) and non-reassociated (Sup) fractions were immunoblotted with the 
anti-HRI mAb F to detect the presence of HRI. None, shows both the 
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Figure 32. Effects of Time and Temperature on the Reconstitution of HRI-Hsp90 
Complex. 
Proteins from 2.5 µl of heme-deficient protein synthesis mixes were 
adsorbed with non-immune control (lanes 1) or the 8D3 anti-hsp90 (lanes 2 
& 3) antibody bound to GAM-agarose as described under "Experimental 
Procedures". Reconstitution reactions were incubated at O ·c (lanes 2) or at 
30 ·c (lanes 1 & 3) for the times indicated in the figure. Hemin was added 
back during the incubation. After incubation, the reassociated fractions 
were analyzed by SDS-PAGE and Western blotting with the anti-HRI mAb 
F to detect the presence of HRI. HC, heavy chain of IgM. 
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Figure 33. Effect of the ECl Antigen on the Reconstitution of HRI-Hsp90 Complex. 
Proteins from 2.5 µl of heme-deficient protein synthesis mixes were first 
adsorbed with the ECl mAb to generate the ECl antigen-free lysate. This 
ECl antigen-free lysate was then used for the second immunoprecipitation 
of hsp90 by the non-immune control (C) or the 8D3 anti-hsp90 (I) antibody 
bound to GAM-agarose in the presence of 20 µM of hemin ( +H) or in the 
absence of hemin (-H) as described under "Experimental Procedures". The 
reassociated (Pel) and non-associated (Sup) fractions were separated by 
SOS-PAGE and Western blotted with the anti-HRI mAb F to detect the 
presence of HRI. HC, heavy chain of IgM. 
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Figure 34. Effect~ of Hsp90 and Hemin on the Reconstitution of HRI-ECl Antigen 
Complex. 
(A) Hsp90 from 2.5 µl of heme-deficient protein synthesis mixes were 
removed with non-immune control (C) or the 8D3 anti-hsp90 (I) antibody 
bound to GAM-agarose. The adsorbed (Pel) and non-adsorbed (Sup) 
fractions were Western blotted with the 4322 anti-hsp90/hsp70 antibody to 
detect the presence of hsp90 and hsp70. (B) The supernatants of (A), 
containing hsp90 (lane 2) or containing no hsp90 (lane 3), were secondly 
immunoprecipitated with the non-immune control (lane 1) or with the ECl 
(lanes 2 & 3) antibody bound to GAG-agarose. The non-adsorbed fractions 
were immunoblotted with the ECl mAb to detect the presence of the ECl 
antigen. Lane 4, 1.25 µl of unincubated whole lysate. (C) 15 µl of the 
diluted (1:10) supernatants of (A) (with hsp90 or without hsp90) were then 
used for the second immunoprecipitation of the ECl antigen by the non-
immune control (C) or the ECl (I) antibody bound to GAG-agarose in the 
presence of 20 mM of hemin ( + H) or in the absence of hemin (-H) at 30 ° C 
for 10 min. The reassociated fractions were separated by SDS-PAGE and 
Western blotted with the anti-HRI mAb F to detect the presence of HRI. L, 
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Figure 35. Conditions for Stripping Heat Shock Proteins from HRI. 
Proteins from 10 µl of hemin-supplemented protein synthesis mixes were 
adsorbed with non-immune control (C) or the anti-HR! (I) antibody bound 
to.GAG-agarose. The resin was washed with TBS at O ·c (lane 1) or with 
TB containing 0.5 M NaCl, 1 mM ATP, and 5 mM Mg++ either at O ·c (lane 
2) or at 30 ·c (lane 3). After washing, samples were analyzed by SDS-
PAGE and Western blotting with the 4322 anti-hsp90/hsp70 antibody to 
detect the presence of hsp90 and hsp70. HC, heavy chain of IgG. 
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Figure 36. Requirement for ATP and Mg++ in Hsp90 Binding to HRI if Hsp70 Is not Pre-
associated with HRI. 
The salt stripped HRI resin was incubated with HRl-free reconstitution 
supematants at 30 °C for 5 min followed by apyrase treatment. The 
samples were then washed with TBS and analyzed by SDS-PAGE and 
Western blotting with the anti-hsp90/hsp70 antibody to detect the presence 
of hsp90 and hsp70. Lane 1, HRI resin, without salt stripping; lane 2, 
control IgG resin, with salt stripping; lane 3, HRI resin, with salt stripping; 
lane 4, salt stripped control IgG resin incubated with reconstitution 
supernatant in the presence of ATP and Mg++; salt stripped HRI resin 
incubated with the reconstitution supernatant in the presence of both ATP 
and Mg++ (lane 5) or in the presence of only ATP (lane 6) or in the presence 
of only Mg++ (lane 7) or in the absence both ATP and Mg++ (lane 8). 
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Figure 37. The Requirement of ATP and Mg++ for the Binding of Hsp90 to the HRI-
Hsp70 Complex. 
Proteins from 2.5 µl of heme-deficient protein synthesis mixes were 
adsorbed with non-immune control (C) or the 8D3 anti-hsp90 (I) antibody 
bound to GAM-agarose. After incubation of the reconstitution reaction 
mixes with hsp90-free supematants for 5 min at 30 °C, the reassociated 
(Pel) and non-associated (Sup) fractions were analyzed by SDS-PAGE and 
Western blotting with the anti-HR! mAb F to detect the presence of HRI. 
The reconstitution conditions are: without hemin (lane 1), with hemin (lanes 
2-5), with ATP and Mg++ (lanes 1-2), without ATP, but with Mg++ (lane 3), 
and with ATP and 5 mM EDTA (lane 4), and with ATP, 5 mM EDTA, and 
lOmMMg++. 
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Figure 38. The Model for Translational Regulation by Heat Shock Proteins. 
HR/, hemin-regulated eIF-2a kinase; A, the active site within HRI; 90, 
thsp90; 70, hsp70; ECJ, the ECl antigen; DP, denatured proteins; NEM, 
N-ethylmaleimide. 
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The translational regulation by heat shock proteins (hsps) at the initiation !stage in 
rabbit reticulocyte lysates has been studied. Hsp90, hsp70 and hsp56 (the ECl *-°tigen) 
I 
interact with the heme-regulated eIF-2a kinase (HRI) and form a HRI-hsps coqiplex in 
i 
rabbit reticulocyte lysates. The association of HRI with hsp90 and the ECl aQtigen is 
I 
dependent upon the presence of hemin at a concentration of at least 5 µM in reti¢ulocyte 
lysates. Hsp70 associates with HRI in both hemin-supplemented and heme-jeficient 
lysates. It is the constitutively expressed form of hsp70, hsc70, that associates jith HRI 
· · 1 1 I m retI.cu ocyte ysates. I 
I 
I 
Three different pathways for activation of HRI in reticulocyte lysates ha~e been 
I 
distinguished. Activation of HRI in heme-deficient lysates correlates with the disspciation 
I 
of hsp90 and the ECl antigen, while hsp70 remains bound to HRI. This type of a9tivation 
is not prevented by the anti-HRI monoclonal antibody (mAb) F. In addition, an alteration 
of the levels of hsp70 bound to HRI is obs~rved. The release of hsp70 from HRI lequires 
the hydrolysis of ATP.. . . . . 
In contrast, act1vat10n of HRI m hemm-supplemented lysates m response to stress 
conditions does not require the dissociation of hsp90 and the ECl antigen. Ad!tion of 
denatured proteins into the hemin-supplemented lysates activates HRI. This lkind of 
activation can be prevented by the anti-HRI mAb F. Denatured proteins bind to hs~70 and 
I 
sequester hsp70 from HRI. Similarly, heat shock induces the activation of HRI in hemin-
supplemented lysates and inhibits protein synthesis. The anti-HRI mAb F can also reverse 
132 
133 
the activation of HRI caused by heat shock. Heat shock blocks the interaction of HRI with 
hsp70. Interestingly, the activation of HRI caused by addition of oxidants into thJ hemin-
supplemented lysates cannot be prevented by the anti-HR! mAb F. Hsp90, hsp70J and the 
ECl antigen remain bound to HRI in such a case. 
The HRI-hsps complex can be reconstituted in vitro. The reassembly df hsp90 
I 
I 
with HRI is hemin-dependent. Elevated temperature facilitates the reconstitutidn of the 
I 
I 
HRI-hsps complex. The ECl antigen is not required for the binding of hsp90 to fIRI. In 
I 
the absence of hsp90, the ECl antigen can associate with HRI. If hsp70 is pre-as~ociated 
with HRI, the reconstitution of hsp90 with HRI does not require ATP, but need~ Mg++. 
However, both ATP and Mg++ are required for the reassembly of hsp90 with HRI jf hsp70 
is not pre-associated with HRI. Based on the observations described above, a model is 
I 
presented for translational regulation by heat shock proteins in rabbit reticulocyte lysates 
(Fig. 38). I 
The Carboxyl Te1minal of Hsp90 Binds to HRI 
To determine the binding site of hsp90 to HRI, we have employed the AC88 anti-
hsp90 mAb (Riehl et al., 1985) and the 07a anti-hsp90 mAb (Brugge et al., 1983). The 
' 
AC88 anti-hsp90 mAb recognizes the carboxyl terminal of hsp90, while the D7a anti-
I 
hsp90 mAb recognizes the amino terminal of hsp90 (Riehl et al., 1985; Brugge et al., 
I 
1983; Smith at al., 1992). When the heme-deficient lysates were preincubated with the 
AC88 mAb, the interaction of HRI with hsp90 was reduced to about 50% (Fig. p9, lane 
3). In contrast, very little inhibition of the binding of hsp90 to HRI was observld when 
the lysates were preincubated with the 07a anti-hsp90 mAb (lane 4) or with ~he non-
1 
immune control antibody (lane 5). The decrease in the binding of hsp90 to HRI c~used by 
I 
the preincubation with the AC88 anti-hsp90 mAb suggests that the AC88 mAb c~mpetes 
with HRI for the binding to hsp90. We also observed that the AC88 mAb b'l31d was 
present in the 8D3 immune pellets after incubation of heme-deficient lysates with ttje AC88 
I 
I 
Figure 39. The Abilities of the AC88 and the D7cx. Anti-hsp90 mAbs to Prevent the 
Binding of HRI to Hsp90. 
Heme-deficient protein synthesis mixes were preincubated on ice for 15 min 
in the presence of no additions (lanes 1 & 2) or in the presence of - lµg 
IgG/10 µl protein synthesis mix of the AC88 anti-hsp90 mAb (lane 3) or the 
D7cx anti-hsp90 mAb (lane 4) or the non-immune control monoclonal IgG 
(MOPC 21 mouse IgG ascites, Sigma) (lane 5). Proteins from 2.5 µl of the 
preincubated heme-deficient protein synthesis mixes were adsorbed with the 
non-immue control (C) or the 8D3 anti-hsp90 (I) antibody bound to GAM-
agarose in the absence of hemin (lane 1) or in the presence of 20 µM of 
hemin (lanes 2-5). The adsorbed fractions were analyzed by SDS-PAGE 
and Western blotting with the anti-HR! mAb F to detect the presence of 
HRI. HC, the heavy chain.of IgM. 
1 2 3 4 5 






mAb (data not shown). The data suggest that the carboxyl terminal of hsp90 is invlolved in 
the interaction with HRI. Preliminary studies using deletion mutants of HRI (protded by 
Dr. J.-J. Chen, M.I.T.) have been carried out to begin mapping regions of HRI !that are 
responsible for its interaction with hsp90 and the EC! antigen. The laboratory p14• future 
studies in conjunction with Dr. Chen's laboratory to further elucidate the domain, present 
in each protein that are involved in the interaction of these proteins and the regu ation of 
HRI activity. 
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